Novartis
twitter hesap

"18.09.2017 12:00:05" #psoriasis, #EADVGen Novartis 🖐 Did you see Novartis announce new #psoriasis data at #EADVGen last week? https://t.co/PMRQ7JtmdK 🖐 Did you see Novartis announce new #psoriasis data at #EADVGen last week? https://t.co/PMRQ7JtmdK
"18.09.2017 06:00:02" #psoriasis, #EADVGen Novartis 📢 Did you see Novartis announce new #psoriasis data at #EADVGen last week? https://t.co/PMRQ7JtmdK 📢 Did you see Novartis announce new #psoriasis data at #EADVGen last week? https://t.co/PMRQ7JtmdK
"16.09.2017 14:17:00" #EADVGen, #CSU, #CIU Novartis ⚡️ New Novartis data in chronic spontaneous urticaria #EADVGen #CSU #CIU https://t.co/IRJfHBS0N8 ⚡️ New Novartis data in chronic spontaneous urticaria #EADVGen #CSU #CIU https://t.co/IRJfHBS0N8
"16.09.2017 12:00:09" #ERSCongress, #SFFB Novartis Sometimes asthma can be so severe that people need to take time off work! #ERSCongress #SFFB https://t.co/xbsQ98xVaK Sometimes asthma can be so severe that people need to take time off work! #ERSCongress #SFFB https://t.co/xbsQ98xVaK
"15.09.2017 20:37:48"  Novartis @joelfinkle We saw your tweet. Apologies for the inconvenience. Pls call our Customer Service Rebate team at 1-855-344-6871 so we can help. @joelfinkle We saw your tweet. Apologies for the inconvenience. Pls call our Customer Service Rebate team at 1-855-344-6871 so we can help.
"15.09.2017 18:32:17" #kissthis4MBC, #metastaticBC Novartis Join us today in Washington Sq Park, NYC as we kick off #kissthis4MBC w/ a very special event in honor of those living w/ #metastaticBC! https://t.co/42lYNPEN5X Join us today in Washington Sq Park, NYC as we kick off #kissthis4MBC w/ a very special event in honor of those living w/ #metastaticBC! https://t.co/42lYNPEN5X
"15.09.2017 15:00:06" #Asthma, #SFFB Novartis #Asthma isn’t just a physical problem. Many people feel the psychological affects too! #SFFB https://t.co/DiBIMNJlEa #Asthma isn’t just a physical problem. Many people feel the psychological affects too! #SFFB https://t.co/DiBIMNJlEa
"15.09.2017 14:08:51" #NextGenScience Novartis Andrei, a breast cancer specialist from Brazil, had the opportunity w/ #NextGenScience to learn more about clinical trials [2/2] https://t.co/83AkJtFQHo Andrei, a breast cancer specialist from Brazil, had the opportunity w/ #NextGenScience to learn more about clinical trials [2/2] https://t.co/83AkJtFQHo
"15.09.2017 12:00:06" #NextGenScience Novartis Andrei just finished a #NextGenScience internship & recently spoke to us about what he's taking away. More: https://t.co/oqIcHxZkLO [1/2] https://t.co/7F3IDGtN0x Andrei just finished a #NextGenScience internship & recently spoke to us about what he's taking away. More: https://t.co/oqIcHxZkLO [1/2] https://t.co/7F3IDGtN0x
"14.09.2017 13:44:42" #KissThis4MBC, #metastaticBC Novartis Today we launch #KissThis4MBC w/ @EvaLongoria to raise money to support research for those with #metastaticBC https://t.co/RxBjaww8o0 https://t.co/of0CRy79If Today we launch #KissThis4MBC w/ @EvaLongoria to raise money to support research for those with #metastaticBC https://t.co/RxBjaww8o0 https://t.co/of0CRy79If
"14.09.2017 12:00:04" #asthma, #ERSCongress Novartis Many #asthma patients still feel that they're limited in the physical activities that they can undertake #ERSCongress https://t.co/I3qu35ELnn Many #asthma patients still feel that they're limited in the physical activities that they can undertake #ERSCongress https://t.co/I3qu35ELnn
"14.09.2017 08:00:04" #COPD, #ERSCongress Novartis We’re excited for the COPD Global Patient Leader Summit. Looking forward to hearing #COPD perspectives from around the world! #ERSCongress We’re excited for the COPD Global Patient Leader Summit. Looking forward to hearing #COPD perspectives from around the world! #ERSCongress
"13.09.2017 15:13:27" #NextGenScience Novartis Patricia, a PhD student from Mexico studying clinical pharmacology, wants to help improve public health #NextGenScience [2/2] https://t.co/N20fQhdtjh Patricia, a PhD student from Mexico studying clinical pharmacology, wants to help improve public health #NextGenScience [2/2] https://t.co/N20fQhdtjh
"13.09.2017 14:30:20" #NextGenScience Novartis Patricia recently completed a #NextGenScience internship at Basel HQ. More: https://t.co/OULLiJjNKv [1/2] https://t.co/UZ9dvb98q7 Patricia recently completed a #NextGenScience internship at Basel HQ. More: https://t.co/OULLiJjNKv [1/2] https://t.co/UZ9dvb98q7
"13.09.2017 12:30:05" #asthma, #ERSCongress, #SFFB Novartis ‘Still Fighting for Breath’ survey data showed that #asthma is still a big burden across the globe! #ERSCongress #SFFB https://t.co/mL8TwHZ1Up ‘Still Fighting for Breath’ survey data showed that #asthma is still a big burden across the globe! #ERSCongress #SFFB https://t.co/mL8TwHZ1Up
"13.09.2017 12:00:04" #psoriasis, #EADVGen Novartis ⚡️Novartis announce new data in #psoriasis at #EADVGen. 📈 More at https://t.co/PMRQ7JtmdK ⚡️Novartis announce new data in #psoriasis at #EADVGen. 📈 More at https://t.co/PMRQ7JtmdK
"13.09.2017 05:52:34" #psoriasis, #EADVGen Novartis 📢 Novartis announce new data in #psoriasis at #EADVGen. 🔬 Find out more at https://t.co/PMRQ7JtmdK 📢 Novartis announce new data in #psoriasis at #EADVGen. 🔬 Find out more at https://t.co/PMRQ7JtmdK
"12.09.2017 13:30:06" #Irma Novartis We continue to stand w/ @RedCross to support relief efforts. Our thoughts are w/ everyone affected by #Irma. https://t.co/Iczp24QlvB We continue to stand w/ @RedCross to support relief efforts. Our thoughts are w/ everyone affected by #Irma. https://t.co/Iczp24QlvB
"12.09.2017 13:00:08" #changetheworld Novartis NEWS: Novartis moves up in @DowJones Sustainability Index and ranks 4th in @FortuneMagazine  #changetheworld list https://t.co/CVp35aS9yt https://t.co/53T6fj7xt2 NEWS: Novartis moves up in @DowJones Sustainability Index and ranks 4th in @FortuneMagazine  #changetheworld list https://t.co/CVp35aS9yt https://t.co/53T6fj7xt2
"12.09.2017 12:54:12"  Novartis @peduti_gabriel We saw your tweet. Please provide your contact info to sic.novartis@novartis.com so we can follow up. @peduti_gabriel We saw your tweet. Please provide your contact info to sic.novartis@novartis.com so we can follow up.
"12.09.2017 07:35:19" #psoriasis, #EADVGen Novartis Novartis is proud to have >10 years’ experience exploring treatments for #psoriasis #EADVGen https://t.co/APBsrnl3F1 Novartis is proud to have >10 years’ experience exploring treatments for #psoriasis #EADVGen https://t.co/APBsrnl3F1
"12.09.2017 06:00:05" #Psoriasis Novartis #Psoriasis is more than skin deep. It can socially isolate and impact day-to-day life https://t.co/u0ztHLHfBl https://t.co/8ErCpXxv89 #Psoriasis is more than skin deep. It can socially isolate and impact day-to-day life https://t.co/u0ztHLHfBl https://t.co/8ErCpXxv89
"11.09.2017 22:00:05" #IHC2017 Novartis Thank you @ihs_official, for another terrific congress! #IHC2017 Thank you @ihs_official, for another terrific congress! #IHC2017
"11.09.2017 13:54:52" #Novartis, #psoriasis, #EADVGen Novartis How many years’ experience do you think #Novartis has investigating treatment options for #psoriasis patients? #EADVGen How many years’ experience do you think #Novartis has investigating treatment options for #psoriasis patients? #EADVGen
"11.09.2017 13:00:08" #Novartis, #ESMO17, #NSCLC, #lungcancer Novartis #Novartis data from #ESMO17 show results for certain patients with mutation-driven #NSCLC. #lungcancer https://t.co/Ig68LSsMxL https://t.co/4GlwZ07OZY #Novartis data from #ESMO17 show results for certain patients with mutation-driven #NSCLC. #lungcancer https://t.co/Ig68LSsMxL https://t.co/4GlwZ07OZY
"11.09.2017 12:17:53" #Novartis, #melanoma, #ESMO17 Novartis New adjuvant #Novartis data focused on BRAF-mutant #melanoma patients. #ESMO17 https://t.co/Ig68LSsMxL https://t.co/osRgBsWBrF New adjuvant #Novartis data focused on BRAF-mutant #melanoma patients. #ESMO17 https://t.co/Ig68LSsMxL https://t.co/osRgBsWBrF
"10.09.2017 22:00:06" #migraine, #IHC2017 Novartis Many people with #migraine self-medicate or stop taking prescribed preventive treatments. #IHC2017 https://t.co/XpYfvGZzoC Many people with #migraine self-medicate or stop taking prescribed preventive treatments. #IHC2017 https://t.co/XpYfvGZzoC
"10.09.2017 19:00:04" #migraine, #IHC2017 Novartis Blurred vision, nausea & fatigue: #migraine is much more than a headache. #IHC2017 https://t.co/o4YvduoxK7 Blurred vision, nausea & fatigue: #migraine is much more than a headache. #IHC2017 https://t.co/o4YvduoxK7
"09.09.2017 19:00:02" #Migraine, #IHC2017 Novartis Back pain & a 3-day headache. #Migraine causes misery around the world. #IHC2017 https://t.co/XKkyb9KNEd Back pain & a 3-day headache. #Migraine causes misery around the world. #IHC2017 https://t.co/XKkyb9KNEd
"09.09.2017 16:00:07" #migraine, #IHC2017 Novartis The science behind #migraine prevention now being presented at #IHC2017 https://t.co/3xkQvb10Tf The science behind #migraine prevention now being presented at #IHC2017 https://t.co/3xkQvb10Tf
"09.09.2017 13:07:40" #retinaldisease, #EURETINA17 Novartis 5 yrs later, we’ve just concluded the largest-ever study on #retinaldisease – learn more #EURETINA17 https://t.co/RRICTgU4sF 5 yrs later, we’ve just concluded the largest-ever study on #retinaldisease – learn more #EURETINA17 https://t.co/RRICTgU4sF
"09.09.2017 10:24:11" #maculardegeneration, #EURETINA17 Novartis We’re presenting 30 abstracts, incl. 16 oral presentations, on #maculardegeneration–take a  👀 ! #EURETINA17!  https://t.co/DSSt9RiOTs We’re presenting 30 abstracts, incl. 16 oral presentations, on #maculardegeneration–take a  👀 ! #EURETINA17!  https://t.co/DSSt9RiOTs
"08.09.2017 17:15:04" #EURETINA17 Novartis See what’s on the horizon for advances in ophthalmology: follow #EURETINA17 https://t.co/caNLtuyMF3 See what’s on the horizon for advances in ophthalmology: follow #EURETINA17 https://t.co/caNLtuyMF3
"08.09.2017 16:16:34" #EURETINA17 Novartis Aging can change your outlook on life. Literally. #EURETINA17 https://t.co/DUG3eqSbhc Aging can change your outlook on life. Literally. #EURETINA17 https://t.co/DUG3eqSbhc
"08.09.2017 16:00:05" #migraine, #IHC2017 Novartis Sensitivity to light, sound & smells: #migraine sufferers often endure these & more. #IHC2017 https://t.co/lj0R5AkGnR Sensitivity to light, sound & smells: #migraine sufferers often endure these & more. #IHC2017 https://t.co/lj0R5AkGnR
"08.09.2017 13:00:08" #EURETINA17 Novartis Tomorrow we’ll be running through Barcelona to raise $$ for sight @orbisintl #EURETINA17 Learn more: https://t.co/vIIH1phpop  🏃🏃🏃🏃🏃 Tomorrow we’ll be running through Barcelona to raise $$ for sight @orbisintl #EURETINA17 Learn more: https://t.co/vIIH1phpop  🏃🏃🏃🏃🏃
"08.09.2017 12:15:36" #changetheworld Novartis Proud to be recognized by @FortuneMagazine for our innovative R&D + work to expand healthcare access #changetheworld https://t.co/HhKm4TATrv https://t.co/Bh5vHX16ez Proud to be recognized by @FortuneMagazine for our innovative R&D + work to expand healthcare access #changetheworld https://t.co/HhKm4TATrv https://t.co/Bh5vHX16ez
"08.09.2017 08:00:06" #malaria Novartis Read @VasNarasimhan’s @FortuneMagazine op-ed about working in partnership to tackle drug-resistant #malaria https://t.co/n4RyQEoAcx https://t.co/fJ8RqgiIwt Read @VasNarasimhan’s @FortuneMagazine op-ed about working in partnership to tackle drug-resistant #malaria https://t.co/n4RyQEoAcx https://t.co/fJ8RqgiIwt
"07.09.2017 20:41:45" #IHC2017, #migraine Novartis Novartis is presenting data at #IHC2017 showing results of their investigational treatment in #migraine prevention https://t.co/mO05DC8A1M Novartis is presenting data at #IHC2017 showing results of their investigational treatment in #migraine prevention https://t.co/mO05DC8A1M
"07.09.2017 20:00:53"  Novartis .@VasNarasimhan writes about his experience working as a doctor in Africa & passion for improving treatment access https://t.co/QXLHr6xZ1a https://t.co/YHGgpYVlJO .@VasNarasimhan writes about his experience working as a doctor in Africa & passion for improving treatment access https://t.co/QXLHr6xZ1a https://t.co/YHGgpYVlJO
"07.09.2017 19:00:04" #migraine, #IHC2017 Novartis Did you know 90% of people report they cannot work or function with #migraine #IHC2017 https://t.co/XQ2z0GQqix Did you know 90% of people report they cannot work or function with #migraine #IHC2017 https://t.co/XQ2z0GQqix
"06.09.2017 14:15:31" #NextGenScience Novartis Giordani, a neurologist from Brazil, on why he’s optimistic when it comes to tackling multiple sclerosis #NextGenScience [2/2] https://t.co/kDZ3Vmu4Dy Giordani, a neurologist from Brazil, on why he’s optimistic when it comes to tackling multiple sclerosis #NextGenScience [2/2] https://t.co/kDZ3Vmu4Dy
"06.09.2017 12:00:09" #NextGenScience Novartis Giordani recently completed a #NextGenScience internship at Basel HQ. More: https://t.co/N1Ik8yASxE [1/2] https://t.co/hzT2F2fwki Giordani recently completed a #NextGenScience internship at Basel HQ. More: https://t.co/N1Ik8yASxE [1/2] https://t.co/hzT2F2fwki
"05.09.2017 13:30:05" #MS Novartis BREAKING NEWS: Novartis announces new data from a study of children and adolescents with #MS. Read more: https://t.co/Ne21WdvB31 BREAKING NEWS: Novartis announces new data from a study of children and adolescents with #MS. Read more: https://t.co/Ne21WdvB31
"05.09.2017 05:34:14" #MS Novartis Today we announced new results from a study of children and adolescents with #MS. Learn more: https://t.co/DfyrXXlfr1 Today we announced new results from a study of children and adolescents with #MS. Learn more: https://t.co/DfyrXXlfr1
"04.09.2017 06:56:37"  Novartis Today we announce Vas Narasimhan as new Novartis CEO from Feb 1, 2018. Thank you 👏 Joe Jimenez for your achievements https://t.co/2VauFSX2Be https://t.co/80YIKxip4I Today we announce Vas Narasimhan as new Novartis CEO from Feb 1, 2018. Thank you 👏 Joe Jimenez for your achievements https://t.co/2VauFSX2Be https://t.co/80YIKxip4I
"03.09.2017 11:35:04" #HeartFailure Novartis More than 60 million people are impacted by #HeartFailure worldwide, yet symptoms are still under-recognized. https://t.co/XYOlgbzNpU https://t.co/fbjmtgmalN More than 60 million people are impacted by #HeartFailure worldwide, yet symptoms are still under-recognized. https://t.co/XYOlgbzNpU https://t.co/fbjmtgmalN
"01.09.2017 13:24:47" #NextGenScience Novartis Aida, a pharmacologist from Uganda, discusses the potential of pharmacometrics. #NextGenScience [2/2] https://t.co/bS7bQ8657i Aida, a pharmacologist from Uganda, discusses the potential of pharmacometrics. #NextGenScience [2/2] https://t.co/bS7bQ8657i
"01.09.2017 08:30:06" #NextGenScience Novartis We’re helping nurture the potential of young scientists like Aida: https://t.co/pP6d7ZynD4 #NextGenScience [1/2] https://t.co/K5XaGmuVHo We’re helping nurture the potential of young scientists like Aida: https://t.co/pP6d7ZynD4 #NextGenScience [1/2] https://t.co/K5XaGmuVHo
"01.09.2017 07:43:42" #Harvey Novartis Our thoughts are w/ everyone affected by #Harvey. We are supporting @RedCross relief efforts. Learn more here: https://t.co/SzKU1VwngE Our thoughts are w/ everyone affected by #Harvey. We are supporting @RedCross relief efforts. Learn more here: https://t.co/SzKU1VwngE
"31.08.2017 15:01:56" #NextGenScience Novartis Peter, a PhD student from Zambia studying pharmaceutical chemistry, on career goals. #NextGenScience [2/2] https://t.co/atWqBStzpD Peter, a PhD student from Zambia studying pharmaceutical chemistry, on career goals. #NextGenScience [2/2] https://t.co/atWqBStzpD
"31.08.2017 12:00:53" #NextGenScience Novartis We’re helping scientists like Peter to further develop their research skills: https://t.co/CUjgz0gwBB #NextGenScience [1/2] https://t.co/4JxP8Lh9F8 We’re helping scientists like Peter to further develop their research skills: https://t.co/CUjgz0gwBB #NextGenScience [1/2] https://t.co/4JxP8Lh9F8
"30.08.2017 16:09:54" #FDA, #CARTcell Novartis Today marked the #FDA approval of the first #CARTcell therapy. https://t.co/LxHNEsTdES Today marked the #FDA approval of the first #CARTcell therapy. https://t.co/LxHNEsTdES
"30.08.2017 15:59:11" #CARTcell, #FDA Novartis Our #CARTcell therapy has been approved by the #FDA https://t.co/g25Stnp9YN https://t.co/UaE7fGQO3n Our #CARTcell therapy has been approved by the #FDA https://t.co/g25Stnp9YN https://t.co/UaE7fGQO3n
"30.08.2017 07:40:03" #HeartFailure Novartis Commonly mistaken as a normal part of aging, swollen feet or ankles can actually be a sign of #HeartFailure. https://t.co/CLPhcXQriW https://t.co/Sp3Zxacjah Commonly mistaken as a normal part of aging, swollen feet or ankles can actually be a sign of #HeartFailure. https://t.co/CLPhcXQriW https://t.co/Sp3Zxacjah
"29.08.2017 09:57:03"  Novartis How would you cope if you were told your heart was failing? 
https://t.co/NlRM2wxGXV https://t.co/JHznavegQx How would you cope if you were told your heart was failing? 
https://t.co/NlRM2wxGXV https://t.co/JHznavegQx
"28.08.2017 18:15:05" #HeartFailure Novartis Do you know the difference between a heart attack and #HeartFailure? We’ll give you a head start… https://t.co/mFML8c5Dqp Do you know the difference between a heart attack and #HeartFailure? We’ll give you a head start… https://t.co/mFML8c5Dqp
"27.08.2017 12:34:52" #ESCCongress Novartis Read more on our latest cancer news and data out of #ESCCongress https://t.co/qeO9RT1xv3 Read more on our latest cancer news and data out of #ESCCongress https://t.co/qeO9RT1xv3
"27.08.2017 10:07:58"  Novartis Read the results from our study investigating inflammation as a treatment target in people with prior heart attack: https://t.co/AcrlEYrvJu Read the results from our study investigating inflammation as a treatment target in people with prior heart attack: https://t.co/AcrlEYrvJu
"25.08.2017 15:00:43" #NovartisAccess Novartis .@BUSPH leads the way with #NovartisAccess in Kenya to weigh the impact of access-to-medicine initiatives https://t.co/aZjNYXbWQs @LancetGH .@BUSPH leads the way with #NovartisAccess in Kenya to weigh the impact of access-to-medicine initiatives https://t.co/aZjNYXbWQs @LancetGH
"25.08.2017 14:17:39" #NextGenScience Novartis Diana, a PhD student from Mexico studying biotechnology, shares a recent breakthrough in the lab during our #NextGenScience program. [2/2] https://t.co/H7OUYm55jA Diana, a PhD student from Mexico studying biotechnology, shares a recent breakthrough in the lab during our #NextGenScience program. [2/2] https://t.co/H7OUYm55jA
"25.08.2017 08:00:05" #NextGenScience Novartis We’re helping talented young scientists gain the skills needed for a research career. More: https://t.co/rAPW3qMHc1 #NextGenScience [1/2] https://t.co/XMYBBP5Hdc We’re helping talented young scientists gain the skills needed for a research career. More: https://t.co/rAPW3qMHc1 #NextGenScience [1/2] https://t.co/XMYBBP5Hdc
"24.08.2017 13:00:07" #digitaltransformation Novartis Today we announced Bertrand Bodson’s appointment as Chief Digital Officer - Welcome @BBOD! #digitaltransformation https://t.co/06pVUFnnO3 https://t.co/JTRTlmBRuk Today we announced Bertrand Bodson’s appointment as Chief Digital Officer - Welcome @BBOD! #digitaltransformation https://t.co/06pVUFnnO3 https://t.co/JTRTlmBRuk
"24.08.2017 12:30:03" #NovartisAccess Novartis @BUSPH leads the way with #NovartisAccess in Kenya to weigh the impact of access-to-medicine initiatives https://t.co/SMtB1x7Wrw @LancetGH @BUSPH leads the way with #NovartisAccess in Kenya to weigh the impact of access-to-medicine initiatives https://t.co/SMtB1x7Wrw @LancetGH
"24.08.2017 11:34:48" #Novartis, #EMA Novartis Bruno Strigini, #Novartis Oncology CEO, on today’s #EMA approval for locally advanced or metastatic breast cancer https://t.co/LSmcQ3lhsW Bruno Strigini, #Novartis Oncology CEO, on today’s #EMA approval for locally advanced or metastatic breast cancer https://t.co/LSmcQ3lhsW
"24.08.2017 10:00:10" #advancedBC Novartis Experiences with #advancedBC can be unique to each patient around the world. Hear their stories: https://t.co/D6I4xbg52Z https://t.co/SjsSqY4U2v Experiences with #advancedBC can be unique to each patient around the world. Hear their stories: https://t.co/D6I4xbg52Z https://t.co/SjsSqY4U2v
"24.08.2017 06:40:09" #EMA, #metastaticBC Novartis Novartis announces #EMA approval for treatment of locally advanced or #metastaticBC. Read more: https://t.co/o7fMu7jI5s Novartis announces #EMA approval for treatment of locally advanced or #metastaticBC. Read more: https://t.co/o7fMu7jI5s
"24.08.2017 06:30:03" #digitaltransformation Novartis This just in: Novartis appoints Bertrand Bodson @BBOD to new role of Chief Digital Officer. #digitaltransformation https://t.co/u6vtna1cNA This just in: Novartis appoints Bertrand Bodson @BBOD to new role of Chief Digital Officer. #digitaltransformation https://t.co/u6vtna1cNA
"23.08.2017 15:00:09" #NovartisAccess Novartis @BUSPH leads the way with #NovartisAccess in Kenya to weigh the impact of access-to-medicine initiatives https://t.co/4ZaqMmEjfS @LancetGH @BUSPH leads the way with #NovartisAccess in Kenya to weigh the impact of access-to-medicine initiatives https://t.co/4ZaqMmEjfS @LancetGH
"23.08.2017 14:30:04" #malaria Novartis “We have to get ahead of this now” our Novartis CMO Vas Narasimhan on fighting #malaria resistance in @Business https://t.co/LRy99ga9Ng “We have to get ahead of this now” our Novartis CMO Vas Narasimhan on fighting #malaria resistance in @Business https://t.co/LRy99ga9Ng
"23.08.2017 14:00:04" #NovartisAccess Novartis @BUSPH leads the way with #NovartisAccess in Kenya to weigh the impact of access-to-medicine initiatives https://t.co/H9dFDsl77w @LancetGH @BUSPH leads the way with #NovartisAccess in Kenya to weigh the impact of access-to-medicine initiatives https://t.co/H9dFDsl77w @LancetGH
"23.08.2017 13:14:20" #NextGenScience Novartis Heather, a researcher studying pharmaceutical chemistry in South Africa, discusses what keeps her motivated. #NextGenScience [2/2] https://t.co/P43pwQmxi1 Heather, a researcher studying pharmaceutical chemistry in South Africa, discusses what keeps her motivated. #NextGenScience [2/2] https://t.co/P43pwQmxi1
"23.08.2017 10:02:20" #ReimagineMedicine Novartis Our research, our purpose is to respond definitively to the toughest diseases of our time #ReimagineMedicine https://t.co/tnRxOLHre5 Our research, our purpose is to respond definitively to the toughest diseases of our time #ReimagineMedicine https://t.co/tnRxOLHre5
"23.08.2017 08:00:10" #NextGenScience Novartis Discover how we’re supporting talented young scientists like Heather: https://t.co/aAKycJTW9h #NextGenScience [1/2] https://t.co/zvPxbTxfT0 Discover how we’re supporting talented young scientists like Heather: https://t.co/aAKycJTW9h #NextGenScience [1/2] https://t.co/zvPxbTxfT0
"21.08.2017 05:33:55" #BREAKING, #malaria Novartis #BREAKING: Novartis & @MedsforMalaria launch trial in Africa for a novel compound against drug-resistant #malaria: https://t.co/wyU8sQcl33 https://t.co/Xyb91X4mUJ #BREAKING: Novartis & @MedsforMalaria launch trial in Africa for a novel compound against drug-resistant #malaria: https://t.co/wyU8sQcl33 https://t.co/Xyb91X4mUJ
"20.08.2017 12:00:05" #WorldMosquitoDay Novartis Malaria is transmitted by female mosquitoes of the Anopheles genus. Stories on the fightback: https://t.co/UjjgUB3gFD #WorldMosquitoDay https://t.co/IaCblFM9GP Malaria is transmitted by female mosquitoes of the Anopheles genus. Stories on the fightback: https://t.co/UjjgUB3gFD #WorldMosquitoDay https://t.co/IaCblFM9GP
"20.08.2017 11:00:09" #WorldMosquitoDay Novartis On #WorldMosquitoDay, we're celebrating people like Agnes, a nurse in Kenya dedicated to fighting malaria: https://t.co/1Xbzicf3zy https://t.co/7rlvvI5Ph7 On #WorldMosquitoDay, we're celebrating people like Agnes, a nurse in Kenya dedicated to fighting malaria: https://t.co/1Xbzicf3zy https://t.co/7rlvvI5Ph7
"20.08.2017 10:34:04" #malaria, #WorldMosquitoDay Novartis Meet a @SwissTPH mosquito wrangler & see the crucial work being done on mosquitoes & mosquito-borne diseases like #malaria #WorldMosquitoDay https://t.co/8kMfrm5vxy Meet a @SwissTPH mosquito wrangler & see the crucial work being done on mosquitoes & mosquito-borne diseases like #malaria #WorldMosquitoDay https://t.co/8kMfrm5vxy
"20.08.2017 10:00:04" #WorldMosquitoDay Novartis Squash some common misconceptions about mosquitoes & malaria. Take this quick quiz: https://t.co/a6rJVQBhyo #WorldMosquitoDay https://t.co/sGec7cDIlH Squash some common misconceptions about mosquitoes & malaria. Take this quick quiz: https://t.co/a6rJVQBhyo #WorldMosquitoDay https://t.co/sGec7cDIlH
"20.08.2017 08:00:06" #WorldMosquitoDay, #malaria Novartis It’s #WorldMosquitoDay, so we’re making some noise about these small insects & a devastating disease they transmit – #malaria. Stay tuned. https://t.co/ySO6fA9UpU It’s #WorldMosquitoDay, so we’re making some noise about these small insects & a devastating disease they transmit – #malaria. Stay tuned. https://t.co/ySO6fA9UpU
"19.08.2017 17:00:07" #WorldMosquitoDay Novartis There’s something in the air we’re itching to share. Turn up the volume and get ready for #WorldMosquitoDay. https://t.co/XiP9k1zF5J There’s something in the air we’re itching to share. Turn up the volume and get ready for #WorldMosquitoDay. https://t.co/XiP9k1zF5J
"18.08.2017 14:14:47" #NextGenScience Novartis Hear more insights from upcoming young researchers like Kuteesa by following #NextGenScience https://t.co/btIlAV9QAX Hear more insights from upcoming young researchers like Kuteesa by following #NextGenScience https://t.co/btIlAV9QAX
"18.08.2017 13:30:30"  Novartis The specter of malaria that resists treatment is real. View scenes from the front line: https://t.co/yuMO1ocOuF https://t.co/T2HL1ki16j The specter of malaria that resists treatment is real. View scenes from the front line: https://t.co/yuMO1ocOuF https://t.co/T2HL1ki16j
"18.08.2017 09:00:05" #NextGenScience Novartis We’re helping talented young scientists gain the skills needed for a research career. More: https://t.co/EVPyoulqkQ [1/2] #NextGenScience https://t.co/lHPg28ThfP We’re helping talented young scientists gain the skills needed for a research career. More: https://t.co/EVPyoulqkQ [1/2] #NextGenScience https://t.co/lHPg28ThfP
"17.08.2017 19:45:02" #ankylosingspondylitis, #ThisASLife Novartis Meet Cookie, an advocate putting a face to #ankylosingspondylitis, on ep. 4 of #ThisASLife Live! w/ @DanReynolds https://t.co/Rm9jym0Sxb Meet Cookie, an advocate putting a face to #ankylosingspondylitis, on ep. 4 of #ThisASLife Live! w/ @DanReynolds https://t.co/Rm9jym0Sxb
"17.08.2017 19:30:03" #ThisASLife, #ankylosingspondylitis Novartis Need some inspiration? Ep. 4 of #ThisASLife Live! w/ #ankylosingspondylitis advocate & blogger Cookie Hopper https://t.co/Rm9jylJh8B https://t.co/ytAAp0vBet Need some inspiration? Ep. 4 of #ThisASLife Live! w/ #ankylosingspondylitis advocate & blogger Cookie Hopper https://t.co/Rm9jylJh8B https://t.co/ytAAp0vBet
"17.08.2017 18:59:56" #ThisASLife, #ankylosingspondylitis Novartis Check out the newest #ThisASLife Live! w/ @DanReynolds & #ankylosingspondylitis advocate and blogger Cookie Hopper https://t.co/Rm9jym0Sxb https://t.co/uzwTiMTrtc Check out the newest #ThisASLife Live! w/ @DanReynolds & #ankylosingspondylitis advocate and blogger Cookie Hopper https://t.co/Rm9jym0Sxb https://t.co/uzwTiMTrtc
"17.08.2017 08:26:17"  Novartis @Omwansu_W Thanks for your interest. You can check here for a list of open internship positions: https://t.co/XP23VOSad5 @Omwansu_W Thanks for your interest. You can check here for a list of open internship positions: https://t.co/XP23VOSad5
"16.08.2017 15:46:12" #ThisASLife Novartis Here’s a 1st look at the new #ThisASLife Live! where Dan learns about the power of gratitude from AS advocate & blogger Cookie Hopper https://t.co/G035bfxbQT Here’s a 1st look at the new #ThisASLife Live! where Dan learns about the power of gratitude from AS advocate & blogger Cookie Hopper https://t.co/G035bfxbQT
"16.08.2017 13:40:58" #NextGenScience Novartis Follow #NextGenScience & discover what drives Thalia & other talented young scientists like her.[2/2] https://t.co/94ydskNTCp Follow #NextGenScience & discover what drives Thalia & other talented young scientists like her.[2/2] https://t.co/94ydskNTCp
"16.08.2017 11:47:55" #immunology, #NextGenScience Novartis Thalia is a PhD student from Mexico specializing in #immunology & is currently on a #NextGenScience internship https://t.co/oqIcHxZkLO [1/2] https://t.co/08kYhU0atf Thalia is a PhD student from Mexico specializing in #immunology & is currently on a #NextGenScience internship https://t.co/oqIcHxZkLO [1/2] https://t.co/08kYhU0atf
"16.08.2017 08:42:43" #malaria Novartis The clock is ticking when it comes to #malaria. Take a quiz & test your knowledge of this life-threatening disease: https://t.co/a6rJVQBhyo https://t.co/Ku2qARciii The clock is ticking when it comes to #malaria. Take a quiz & test your knowledge of this life-threatening disease: https://t.co/a6rJVQBhyo https://t.co/Ku2qARciii
"14.08.2017 12:40:08" #malaria Novartis Mosquitoes suck the potential of millions of people in Africa. Get a factsheet on access to #malaria treatment here: https://t.co/uXymMDyJrA https://t.co/G4jpYLDtRI Mosquitoes suck the potential of millions of people in Africa. Get a factsheet on access to #malaria treatment here: https://t.co/uXymMDyJrA https://t.co/G4jpYLDtRI
"11.08.2017 13:03:39" #NextGenScience Novartis Follow #NextGenScience to discover what drives Carolina & other talented young scientists like her. More here: https://t.co/oqIcHxZkLO [2/2] https://t.co/zNxhN34fJR Follow #NextGenScience to discover what drives Carolina & other talented young scientists like her. More here: https://t.co/oqIcHxZkLO [2/2] https://t.co/zNxhN34fJR
"11.08.2017 13:00:52" #NextGenScience Novartis Carolina is a PhD student from Argentina specializing in molecular oncology & she's at Basel HQ for the #NextGenScience program. [1/2] https://t.co/xMs2v3cafY Carolina is a PhD student from Argentina specializing in molecular oncology & she's at Basel HQ for the #NextGenScience program. [1/2] https://t.co/xMs2v3cafY
"10.08.2017 12:13:01" #malaria Novartis It's time to secure gains made against #malaria & tackle antimalarial drug resistance. Our contribution here: https://t.co/lAZ8Z7x56a https://t.co/w7GKq6mSHp It's time to secure gains made against #malaria & tackle antimalarial drug resistance. Our contribution here: https://t.co/lAZ8Z7x56a https://t.co/w7GKq6mSHp
"10.08.2017 12:08:03"  Novartis @barthk12 @barthk12 We saw your tweet. Please provide your contact info to austria.pharmacovigilance@novartis.com so we can follow up. @barthk12 @barthk12 We saw your tweet. Please provide your contact info to austria.pharmacovigilance@novartis.com so we can follow up.
"09.08.2017 15:20:47" #NextGenScience Novartis Click here to learn more about the program: https://t.co/oqIcHygVDm #NextGenScience [3/3] https://t.co/R43VSxgi1L Click here to learn more about the program: https://t.co/oqIcHygVDm #NextGenScience [3/3] https://t.co/R43VSxgi1L
"09.08.2017 15:18:42" #NextGenScience Novartis Follow #NextGenScience to meet some of the other 2017 NGS interns [2/3] https://t.co/AaLUbd072L Follow #NextGenScience to meet some of the other 2017 NGS interns [2/3] https://t.co/AaLUbd072L
"09.08.2017 15:15:04"  Novartis Anthony is one of 23 talented young scientists from 11 low- & middle-income countries currently at Basel HQ on a 3-month internship [1/3] https://t.co/nIXiIeeRuu Anthony is one of 23 talented young scientists from 11 low- & middle-income countries currently at Basel HQ on a 3-month internship [1/3] https://t.co/nIXiIeeRuu
"09.08.2017 13:57:08"  Novartis @ModelPsoriasis @ModelPsoriasis We saw your tweet. Please provide your contact info to ims-pvo.phnlar@novartis.com so we can follow up. @ModelPsoriasis @ModelPsoriasis We saw your tweet. Please provide your contact info to ims-pvo.phnlar@novartis.com so we can follow up.
"09.08.2017 10:00:06" #cancer, #RNAi Novartis We scoured human #cancer cells for drug targets with #RNAi and published results today in @CellCellPress https://t.co/P4708jI2Or https://t.co/SUxqiZTiwq We scoured human #cancer cells for drug targets with #RNAi and published results today in @CellCellPress https://t.co/P4708jI2Or https://t.co/SUxqiZTiwq
"07.08.2017 18:20:49"  Novartis @hojo666 @hojo666 We saw your tweet. Please provide your contact info to usdrugsafety.operations@novartis.com so we can follow up. @hojo666 @hojo666 We saw your tweet. Please provide your contact info to usdrugsafety.operations@novartis.com so we can follow up.
"03.08.2017 16:32:16" #genetic, #cancer Novartis How can mapping #genetic dependencies in #cancer point to potential drug targets? https://t.co/P4708jI2Or https://t.co/6tyvopMcjx How can mapping #genetic dependencies in #cancer point to potential drug targets? https://t.co/P4708jI2Or https://t.co/6tyvopMcjx
"03.08.2017 11:52:37"  Novartis ⚡️ “Malaria: the next stage in the fightback  ” by @Novartis

https://t.co/6OFGdjir6O ⚡️ “Malaria: the next stage in the fightback  ” by @Novartis

https://t.co/6OFGdjir6O
"26.07.2017 14:00:03" #NextGenScience Novartis In photos: Meet the researcher exploring Ghana's rainforest to help find a cure for deadly diseases. #NextGenScience https://t.co/QdeErzWacJ In photos: Meet the researcher exploring Ghana's rainforest to help find a cure for deadly diseases. #NextGenScience https://t.co/QdeErzWacJ
"25.07.2017 13:25:12"  Novartis @D84569572 We saw your tweet. Please provide your contact info and location to nps.safetydesk@novartis.com so we can follow up. @D84569572 We saw your tweet. Please provide your contact info and location to nps.safetydesk@novartis.com so we can follow up.
"25.07.2017 06:15:24" #cancer Novartis Sandoz expands partnership with @WChildCancer to help children access #cancer treatment in four developing countries https://t.co/KuHdgavisn Sandoz expands partnership with @WChildCancer to help children access #cancer treatment in four developing countries https://t.co/KuHdgavisn
"24.07.2017 15:53:42"  Novartis ⚡️ “@VasNarasimhan visiting Ghana”

https://t.co/2mL1ZzcnrS ⚡️ “@VasNarasimhan visiting Ghana”

https://t.co/2mL1ZzcnrS
"21.07.2017 11:48:10" #Novartis, #CHMP, #AML, #mastocytosis Novartis #Novartis receives positive #CHMP opinion for Tx of #AML & 3 types of advanced systemic #mastocytosis in the EU https://t.co/ohazvMbTeo #Novartis receives positive #CHMP opinion for Tx of #AML & 3 types of advanced systemic #mastocytosis in the EU https://t.co/ohazvMbTeo
"20.07.2017 21:37:04"  Novartis Our chairman talks about how public-private partnerships could help tackle antimicrobial resistance.https://t.co/k4TzMY6jvl Our chairman talks about how public-private partnerships could help tackle antimicrobial resistance.https://t.co/k4TzMY6jvl
"20.07.2017 17:12:38"  Novartis Could the global fight against malaria provide lessons to organize the response to antimicrobial resistance? https://t.co/k4TzMY6jvl Could the global fight against malaria provide lessons to organize the response to antimicrobial resistance? https://t.co/k4TzMY6jvl
"18.07.2017 12:00:09" #innovation Novartis Today we announced our second quarter results, filled with great #innovation - learn more here, https://t.co/nvWMg91jsW $NVS https://t.co/QobaXRcmH9 Today we announced our second quarter results, filled with great #innovation - learn more here, https://t.co/nvWMg91jsW $NVS https://t.co/QobaXRcmH9
"18.07.2017 05:20:47"  Novartis NEWS: Our second quarter results are in, with great progress on three of our development programs, learn more https://t.co/nvWMg91jsW $NVS NEWS: Our second quarter results are in, with great progress on three of our development programs, learn more https://t.co/nvWMg91jsW $NVS
"14.07.2017 16:10:24"  Novartis ⚡️ “CAR-T Cell Therapy”

https://t.co/DtSIzI3Pwo ⚡️ “CAR-T Cell Therapy”

https://t.co/DtSIzI3Pwo
"13.07.2017 08:44:08"  Novartis Our recent European study found that severe asthma is still under-recognized and uncontrolled @lungdiseasenews https://t.co/hLGb4xHMJG Our recent European study found that severe asthma is still under-recognized and uncontrolled @lungdiseasenews https://t.co/hLGb4xHMJG
"12.07.2017 21:49:01" #FDA, #oncology, #adcomm Novartis See our press release regarding #FDA #oncology #adcomm positive recommendation https://t.co/ZZxlKCfm5D See our press release regarding #FDA #oncology #adcomm positive recommendation https://t.co/ZZxlKCfm5D
"12.07.2017 19:33:44" #FDA, #Adcomm Novartis The #FDA #Adcomm has unanimously issued a positive recommendation for our CAR-T cell therapy https://t.co/Dzo02dFRy2 The #FDA #Adcomm has unanimously issued a positive recommendation for our CAR-T cell therapy https://t.co/Dzo02dFRy2
"10.07.2017 13:01:04" #ZeroLeprosy Novartis Today @NovartisFDN & partners call for a global effort to make leprosy history in @TheLancetInfDis. #ZeroLeprosy https://t.co/SphcmJd0wz https://t.co/UKepVjwf4G Today @NovartisFDN & partners call for a global effort to make leprosy history in @TheLancetInfDis. #ZeroLeprosy https://t.co/SphcmJd0wz https://t.co/UKepVjwf4G
"08.07.2017 11:00:05" #NovartisAccess Novartis Agreement signed with Uganda to provide better access to medicines against chronic diseases https://t.co/wB569fZbLE  #NovartisAccess https://t.co/xbHTcbpFbA Agreement signed with Uganda to provide better access to medicines against chronic diseases https://t.co/wB569fZbLE  #NovartisAccess https://t.co/xbHTcbpFbA
"07.07.2017 21:53:32"  Novartis @degs01 We saw your tweet. Please provide your contact info to  commercialqa.phgbfr@novartis.com so we can follow up. @degs01 We saw your tweet. Please provide your contact info to  commercialqa.phgbfr@novartis.com so we can follow up.
"07.07.2017 15:03:41" #NextGenScience Novartis @NobelPrize From one generation to the next: #NextGenScience alumna Phuti Chelopo shared w/ the class of 2017 her experience in scientific research. https://t.co/6TOuHa4HND @NobelPrize From one generation to the next: #NextGenScience alumna Phuti Chelopo shared w/ the class of 2017 her experience in scientific research. https://t.co/6TOuHa4HND
"07.07.2017 14:11:06" #NextGenerationScientists Novartis @NobelPrize Dedication unites all #NextGenerationScientists. Nobel laureate Kurt Wüthrich recently discussed his own pursuit of scientific discovery. https://t.co/F3Gapd3yWD @NobelPrize Dedication unites all #NextGenerationScientists. Nobel laureate Kurt Wüthrich recently discussed his own pursuit of scientific discovery. https://t.co/F3Gapd3yWD
"06.07.2017 12:30:03" #CHMP, #scalp, #psoriasis Novartis NEWS: Novartis treatment receives #CHMP approval for label update in Europe #scalp #psoriasis https://t.co/qo7eJoLjAW NEWS: Novartis treatment receives #CHMP approval for label update in Europe #scalp #psoriasis https://t.co/qo7eJoLjAW
"06.07.2017 11:54:37" #NextGenerationScientists, #NextGenScience Novartis What would u ask a @NobelPrize winner? This week, our #NextGenerationScientists met Nobel laureate Kurt Wüthrich. #NextGenScience https://t.co/LLDMRK2wQu What would u ask a @NobelPrize winner? This week, our #NextGenerationScientists met Nobel laureate Kurt Wüthrich. #NextGenScience https://t.co/LLDMRK2wQu
"06.07.2017 06:09:49" #CHMP, #scalp, #psoriasis Novartis #CHMP approves label update for Novartis drug in Europe #scalp #psoriasis https://t.co/J36qKvZzje https://t.co/LLandb09fw #CHMP approves label update for Novartis drug in Europe #scalp #psoriasis https://t.co/J36qKvZzje https://t.co/LLandb09fw
"04.07.2017 14:30:10" #NextGenerationScientists Novartis We’re joined today by Nobel laureate Kurt Wüthrich. Stay tuned to hear his advice for our 2017 class of #NextGenerationScientists https://t.co/K1yK2ohR1N We’re joined today by Nobel laureate Kurt Wüthrich. Stay tuned to hear his advice for our 2017 class of #NextGenerationScientists https://t.co/K1yK2ohR1N
"03.07.2017 14:39:07" #LMICs Novartis 23 young scientists from 11 #LMICs are with us for 3 months this summer at our Basel HQ - learn why: https://t.co/xctZqO2VtP https://t.co/gyTXGleY0c 23 young scientists from 11 #LMICs are with us for 3 months this summer at our Basel HQ - learn why: https://t.co/xctZqO2VtP https://t.co/gyTXGleY0c
"03.07.2017 13:00:18" #NextGenScience Novartis Research on giraffes by #NextGenScience 2015 grad Edson Barongo Ishengoma may shed light on human diseases. Read how https://t.co/yhkSxO88N5 Research on giraffes by #NextGenScience 2015 grad Edson Barongo Ishengoma may shed light on human diseases. Read how https://t.co/yhkSxO88N5
"29.06.2017 13:00:09" #NextGenerationScientists, #throwback, #tbt Novartis Before we introduce you to this year’s #NextGenerationScientists, here’s a #throwback to the class of 2016: https://t.co/D5wEiZNdkh #tbt https://t.co/DC7t2oTQ17 Before we introduce you to this year’s #NextGenerationScientists, here’s a #throwback to the class of 2016: https://t.co/D5wEiZNdkh #tbt https://t.co/DC7t2oTQ17
"29.06.2017 11:43:48" #Novartis, #NSCLC Novartis First-line use of a #Novartis therapy for patients w/ ALK+ advanced #NSCLC receives EU approval: https://t.co/IJfzSBbVKp https://t.co/5xw5BQyb9t First-line use of a #Novartis therapy for patients w/ ALK+ advanced #NSCLC receives EU approval: https://t.co/IJfzSBbVKp https://t.co/5xw5BQyb9t
"28.06.2017 16:00:05" #AML, #EHA22 Novartis From nurse to patient: facing #AML. Read about Ilana’s journey & how she’s helping others in the community: https://t.co/sXXHyC5gwH #EHA22 From nurse to patient: facing #AML. Read about Ilana’s journey & how she’s helping others in the community: https://t.co/sXXHyC5gwH #EHA22
"27.06.2017 13:00:04" #EAN2017 Novartis Thank you #EAN2017, for another terrific congress Thank you #EAN2017, for another terrific congress
"27.06.2017 10:00:06" #migraine, #EAN2017 Novartis Depression is almost two times more frequent in people with #migraine #EAN2017. https://t.co/DbBSGWrtck https://t.co/k2gxRdkNCH Depression is almost two times more frequent in people with #migraine #EAN2017. https://t.co/DbBSGWrtck https://t.co/k2gxRdkNCH
"26.06.2017 18:35:22"  Novartis @panjpiyare We saw your tweet. Please provide your contact info to ftw.medical_safety@alcon.com so we can follow up. @panjpiyare We saw your tweet. Please provide your contact info to ftw.medical_safety@alcon.com so we can follow up.
"26.06.2017 09:40:59"  Novartis Migraine has been plaguing people for years. Learn more about the path to progress. https://t.co/M2e9P8FuQh Migraine has been plaguing people for years. Learn more about the path to progress. https://t.co/M2e9P8FuQh
"25.06.2017 07:00:05" #migraine, #EAN2017 Novartis Global data shows that #migraine contributes to 446 years lived with disability for every 100,000 #EAN2017 https://t.co/f8NAoCNApT https://t.co/Bn5vqL5tzc Global data shows that #migraine contributes to 446 years lived with disability for every 100,000 #EAN2017 https://t.co/f8NAoCNApT https://t.co/Bn5vqL5tzc
"24.06.2017 15:30:04" #CML, #EHA2017 Novartis New 96-wk results from ENESTfreedom study in Ph+ #CML-CP patients-starting now at #EHA2017! https://t.co/EeV4uKC2Sv New 96-wk results from ENESTfreedom study in Ph+ #CML-CP patients-starting now at #EHA2017! https://t.co/EeV4uKC2Sv
"24.06.2017 14:25:03" #EAN2017 Novartis We’re looking forward to attending @EANeurology 3rd Annual Congress with @Amgen #EAN2017 https://t.co/dpCcZnWuHb We’re looking forward to attending @EANeurology 3rd Annual Congress with @Amgen #EAN2017 https://t.co/dpCcZnWuHb
"23.06.2017 16:19:24" #AML Novartis We are pleased to announce the publication of data from our Phase III #AML trial w/ @ALLIANCE_org in @NEJM https://t.co/Zc8xvp7neZ We are pleased to announce the publication of data from our Phase III #AML trial w/ @ALLIANCE_org in @NEJM https://t.co/Zc8xvp7neZ
"23.06.2017 15:15:05" #EHA2017, #CML Novartis Now presenting at #EHA2017: 96-wk update of ENESTop study in Ph+ #CML-CP patients https://t.co/EeV4uKC2Sv Now presenting at #EHA2017: 96-wk update of ENESTop study in Ph+ #CML-CP patients https://t.co/EeV4uKC2Sv
"23.06.2017 13:00:08" #CHMP, #Novartis Novartis Positive #CHMP opinion for #Novartis advanced breast cancer treatment announced today. Read more: https://t.co/Xxs4X2Uquk Positive #CHMP opinion for #Novartis advanced breast cancer treatment announced today. Read more: https://t.co/Xxs4X2Uquk
"23.06.2017 12:00:06" #EHA22 Novartis A scientist demonstrates the cryopreserved leukapheresis process for CAR-T cell therapy #EHA22 https://t.co/7aHKX5JZQe A scientist demonstrates the cryopreserved leukapheresis process for CAR-T cell therapy #EHA22 https://t.co/7aHKX5JZQe
"23.06.2017 11:00:10"  Novartis Over the past 5 years, Novartis has presented/published 1,028+ papers and abstracts in breast cancer to advance science & improve knowledge. https://t.co/wA2ShSei2u Over the past 5 years, Novartis has presented/published 1,028+ papers and abstracts in breast cancer to advance science & improve knowledge. https://t.co/wA2ShSei2u
"23.06.2017 09:57:51" #CHMP, #metastaticBC Novartis BREAKING: #CHMP recommends EU approval of Novartis #metastaticBC treatment https://t.co/Xxs4X2CP5K BREAKING: #CHMP recommends EU approval of Novartis #metastaticBC treatment https://t.co/Xxs4X2CP5K
"23.06.2017 07:00:35" #EHA22 Novartis CAR-T cell therapy data at #EHA22: https://t.co/trDCwqwUmU CAR-T cell therapy data at #EHA22: https://t.co/trDCwqwUmU
"23.06.2017 06:00:53" #Novartis, #NSCLC Novartis US Only: @US_FDA approves #Novartis targeted therapy for advanced #NSCLC https://t.co/FopgRmEvDn US Only: @US_FDA approves #Novartis targeted therapy for advanced #NSCLC https://t.co/FopgRmEvDn
"22.06.2017 21:56:36" #FDA, #Novartis, #NSCLC Novartis US Only: #FDA approves #Novartis therapy option for certain patients with metastatic #NSCLC https://t.co/FopgRmEvDn https://t.co/ju9ec4rxyV US Only: #FDA approves #Novartis therapy option for certain patients with metastatic #NSCLC https://t.co/FopgRmEvDn https://t.co/ju9ec4rxyV
"22.06.2017 10:00:03" #GlobalGoals, #SwissSustainability Novartis Novartis hosts event on role of Swiss businesses in achieving #GlobalGoals. Join the debate #SwissSustainability https://t.co/cGMHChiG0q Novartis hosts event on role of Swiss businesses in achieving #GlobalGoals. Join the debate #SwissSustainability https://t.co/cGMHChiG0q
"22.06.2017 06:25:31" #HeartAttack Novartis Today we announced results from a new study in people with prior #HeartAttack. Read more: https://t.co/CI5WAuWwJ1 Today we announced results from a new study in people with prior #HeartAttack. Read more: https://t.co/CI5WAuWwJ1
"21.06.2017 16:00:10" #EHA2017 Novartis Join us at #EHA2017 to learn the latest in CAR-T cell therapy. https://t.co/VQ3a8ZHAd4 Join us at #EHA2017 to learn the latest in CAR-T cell therapy. https://t.co/VQ3a8ZHAd4
"21.06.2017 08:30:04" #BillionBreaths Novartis Novartis is proud to announce that #BillionBreaths is nearly here! They’re ready…are you?  https://t.co/VqEWnwvR1B Novartis is proud to announce that #BillionBreaths is nearly here! They’re ready…are you?  https://t.co/VqEWnwvR1B
"21.06.2017 05:42:53" #migraine Novartis Novartis advances #migraine program w/ EMA regulatory filing acceptance. https://t.co/bPLNyCF4oC Novartis advances #migraine program w/ EMA regulatory filing acceptance. https://t.co/bPLNyCF4oC
"20.06.2017 13:30:03" #asthma Novartis Allergic #asthma can significantly restrict those with the condition. Symptom control is essential for patients to feel comfortable. Allergic #asthma can significantly restrict those with the condition. Symptom control is essential for patients to feel comfortable.
"20.06.2017 12:13:04" #asthma Novartis Many #asthma patients still feel that they're limited in the physical activities that they can undertake. https://t.co/sXUGMBV4hK Many #asthma patients still feel that they're limited in the physical activities that they can undertake. https://t.co/sXUGMBV4hK
"20.06.2017 11:30:06" #asthma Novartis Take back control of your #asthma! Correct control of your allergies is essential for a good quality of life. https://t.co/aeIUUdHXfF Take back control of your #asthma! Correct control of your allergies is essential for a good quality of life. https://t.co/aeIUUdHXfF
"20.06.2017 09:00:47" #asthma, #eaaci2017, #BillionBreaths Novartis ‘Still Fighting for Breath’ survey data showed that #asthma is still a big burden #eaaci2017 #BillionBreaths. https://t.co/zDXS8l2O6E ‘Still Fighting for Breath’ survey data showed that #asthma is still a big burden #eaaci2017 #BillionBreaths. https://t.co/zDXS8l2O6E
"20.06.2017 08:22:27" #neovascular, #maculardegeneration Novartis 20 – 25M people worldwide are affected by #neovascular #maculardegeneration. Here’s what we’re doing about it: https://t.co/qBcqpguYWL 20 – 25M people worldwide are affected by #neovascular #maculardegeneration. Here’s what we’re doing about it: https://t.co/qBcqpguYWL
"20.06.2017 07:06:07" #EAACI2017, #chronicurticaria Novartis #EAACI2017: Novartis study highlights urgent need to improve #chronicurticaria management https://t.co/7pOcA0B9s3 https://t.co/vxuug4X4Hg #EAACI2017: Novartis study highlights urgent need to improve #chronicurticaria management https://t.co/7pOcA0B9s3 https://t.co/vxuug4X4Hg
"19.06.2017 13:45:02" #HCP, #medics, #COPD, #ATS2017 Novartis #HCP & #medics: Visit our #COPD Knowledge Centre on @epgonline to watch our #ATS2017 meetings on demand https://t.co/oPVqUZstN5 #HCP & #medics: Visit our #COPD Knowledge Centre on @epgonline to watch our #ATS2017 meetings on demand https://t.co/oPVqUZstN5
"16.06.2017 21:27:44"  Novartis @pamelakarnbach We saw your tweet. Please provide your contact info and location to complaints.phchrk@novartis.com so we can follow up. @pamelakarnbach We saw your tweet. Please provide your contact info and location to complaints.phchrk@novartis.com so we can follow up.
"16.06.2017 17:00:06" #malaria, #DAC2017 Novartis Dismus Mwalukwanda is helping children with #malaria in Zambia, riding his cycle-ambulance. #DAC2017 https://t.co/XLJLY0H7Tb https://t.co/NOnsCAtFXP Dismus Mwalukwanda is helping children with #malaria in Zambia, riding his cycle-ambulance. #DAC2017 https://t.co/XLJLY0H7Tb https://t.co/NOnsCAtFXP
"16.06.2017 15:00:07" #Malaria, #DAC2017 Novartis #Malaria kills a child in Africa every 2 minutes. Nathan is proud to help in Kenya. #DAC2017 https://t.co/TEqhM8oLDj #Malaria kills a child in Africa every 2 minutes. Nathan is proud to help in Kenya. #DAC2017 https://t.co/TEqhM8oLDj
"16.06.2017 12:16:36" #EULAR2017, #MissionRemission, #AS, #PsA Novartis Launching at #EULAR2017, our #MissionRemission campaign encourages doctors and patients to work together to achieve #AS and #PsA remission https://t.co/ulbjxu2bwL Launching at #EULAR2017, our #MissionRemission campaign encourages doctors and patients to work together to achieve #AS and #PsA remission https://t.co/ulbjxu2bwL
"16.06.2017 11:00:09" #malaria, #DAC2017 Novartis Education is power: our toolkit helps stimulate discussions with children about #malaria #DAC2017 https://t.co/13jZCCwybV https://t.co/I42IIPjuzl Education is power: our toolkit helps stimulate discussions with children about #malaria #DAC2017 https://t.co/13jZCCwybV https://t.co/I42IIPjuzl
"16.06.2017 07:30:04" #DayoftheAfricanChild Novartis On #DayoftheAfricanChild, the world reflects on challenges faced by African children, and how we can act to better protect & empower them. https://t.co/WYW2SePKyl On #DayoftheAfricanChild, the world reflects on challenges faced by African children, and how we can act to better protect & empower them. https://t.co/WYW2SePKyl
"16.06.2017 06:00:06" #PsoriaticArthritis Novartis #PsoriaticArthritis is a painful disease with a big impact on quality of life. Share your story https://t.co/5Jlwh9Lf64 https://t.co/dcBAyUScMH #PsoriaticArthritis is a painful disease with a big impact on quality of life. Share your story https://t.co/5Jlwh9Lf64 https://t.co/dcBAyUScMH
"15.06.2017 13:37:55" #MissionRemission, #EULAR2017 Novartis Encouraging open patient and doctor communication, the new #MissionRemission video launches at #EULAR2017 and on @ThisASLife and @PsAndMe https://t.co/srszocBXuD Encouraging open patient and doctor communication, the new #MissionRemission video launches at #EULAR2017 and on @ThisASLife and @PsAndMe https://t.co/srszocBXuD
"15.06.2017 12:00:06"  Novartis Newly-discovered protein provides a potential tool for targeted drug delivery 
https://t.co/pgwGLghxpZ https://t.co/akoVuXFST7 Newly-discovered protein provides a potential tool for targeted drug delivery 
https://t.co/pgwGLghxpZ https://t.co/akoVuXFST7
"15.06.2017 12:00:05" #EULAR2017, #AnkylosingSpondylitis, #PsoriaticArthritis Novartis #EULAR2017 3 year safety & efficacy data in #AnkylosingSpondylitis #PsoriaticArthritis https://t.co/w1wRD6eVZi #EULAR2017 3 year safety & efficacy data in #AnkylosingSpondylitis #PsoriaticArthritis https://t.co/w1wRD6eVZi
"15.06.2017 05:42:05" #AnkylosingSpondylitis, #EULAR2017, #Rheum Novartis 3 year safety & efficacy data in #AnkylosingSpondylitis at #EULAR2017 #Rheum https://t.co/w1wRD6wwQQ 3 year safety & efficacy data in #AnkylosingSpondylitis at #EULAR2017 #Rheum https://t.co/w1wRD6wwQQ
"14.06.2017 15:30:09" #AnkylosingSpondylitis Novartis Men are two to three times more likely than women to develop #AnkylosingSpondylitis. Find out more https://t.co/CbU0c8DRfY https://t.co/2hRhAfp9Hh Men are two to three times more likely than women to develop #AnkylosingSpondylitis. Find out more https://t.co/CbU0c8DRfY https://t.co/2hRhAfp9Hh
"14.06.2017 12:00:06" #WeWontRest Novartis As he hands over @EFPIA presidency, our CEO J Jimenez pledges industry’s commitment to improving lives #WeWontRest https://t.co/CPeRiKwSV7 https://t.co/NJz5mUvhmT As he hands over @EFPIA presidency, our CEO J Jimenez pledges industry’s commitment to improving lives #WeWontRest https://t.co/CPeRiKwSV7 https://t.co/NJz5mUvhmT
"14.06.2017 07:08:27" #AnkylosingSpondylitis Novartis #AnkylosingSpondylitis is a type of arthritis that affects the spine. Who do you think is most likely to develop it? #AnkylosingSpondylitis is a type of arthritis that affects the spine. Who do you think is most likely to develop it?
"13.06.2017 06:00:04"  Novartis Novartis team—led by twin brothers—discovers a tiny protein that challenges assumptions about the genome
https://t.co/QAYuL4wF6l https://t.co/uxKkrFO9mJ Novartis team—led by twin brothers—discovers a tiny protein that challenges assumptions about the genome
https://t.co/QAYuL4wF6l https://t.co/uxKkrFO9mJ
"12.06.2017 15:00:09" #CataractAwarenessMonth Novartis 24M ppl are living w/ cataracts in the U.S. Learn more about the latest treatment options @ https://t.co/ys4CnxODWZ. #CataractAwarenessMonth https://t.co/QQr0laC6bU 24M ppl are living w/ cataracts in the U.S. Learn more about the latest treatment options @ https://t.co/ys4CnxODWZ. #CataractAwarenessMonth https://t.co/QQr0laC6bU
"11.06.2017 19:00:08" #migraine, #AHS17BOS Novartis 32% of those with #migraine reported avoiding making plans for fear of cancellation due to migraine #AHS17BOS https://t.co/abKRNpofZj https://t.co/pDZfciLIK6 32% of those with #migraine reported avoiding making plans for fear of cancellation due to migraine #AHS17BOS https://t.co/abKRNpofZj https://t.co/pDZfciLIK6
"11.06.2017 13:00:07" #migraine, #AHS17BOS Novartis Answer! 90% of people report they cannot work or function with #migraine #AHS17BOS https://t.co/mG2FXA3Owp https://t.co/ykn8lWV9Nr Answer! 90% of people report they cannot work or function with #migraine #AHS17BOS https://t.co/mG2FXA3Owp https://t.co/ykn8lWV9Nr
"10.06.2017 16:00:05" #AHS17BOS Novartis More than a third of people with migraine believed they would be better partners without their headaches #AHS17BOS https://t.co/f8NAoCNApT https://t.co/Vudx0z3Z47 More than a third of people with migraine believed they would be better partners without their headaches #AHS17BOS https://t.co/f8NAoCNApT https://t.co/Vudx0z3Z47
"09.06.2017 13:18:34" #migraine, #AHS17BOS Novartis Test your knowledge: ___ % of people report they cannot work or function with #migraine #AHS17BOS Test your knowledge: ___ % of people report they cannot work or function with #migraine #AHS17BOS
"09.06.2017 13:00:14" #AHS17BOS Novartis Migraine negatively affects time w/ family and friends. 45% reported missing family or social events #AHS17BOS https://t.co/gxThOBZsR0 https://t.co/K1c32NX6Ce Migraine negatively affects time w/ family and friends. 45% reported missing family or social events #AHS17BOS https://t.co/gxThOBZsR0 https://t.co/K1c32NX6Ce
"08.06.2017 20:44:08" #AHS17BOS, #migraine Novartis Novartis highlights new data at #AHS17BOS in #migraine prevention https://t.co/xPK5EPR9vw Novartis highlights new data at #AHS17BOS in #migraine prevention https://t.co/xPK5EPR9vw
"08.06.2017 14:30:10" #migraine, #AHS17BOS Novartis There is no single test to diagnose #migraine. >40% of patients go undiagnosed #AHS17BOS https://t.co/unikHJypJ8 There is no single test to diagnose #migraine. >40% of patients go undiagnosed #AHS17BOS https://t.co/unikHJypJ8
"08.06.2017 13:00:06" #EULAR2017 Novartis 👋 to everyone attending #EULAR2017 – We’re here all week and will be presenting some new data! Watch this space! 👋 to everyone attending #EULAR2017 – We’re here all week and will be presenting some new data! Watch this space!
"08.06.2017 12:00:04" #migraine, #AHS17BOS Novartis There is no single test to diagnose #migraine. >40% of patients go undiagnosed #AHS17BOS https://t.co/UNOt2uvkNd There is no single test to diagnose #migraine. >40% of patients go undiagnosed #AHS17BOS https://t.co/UNOt2uvkNd
"07.06.2017 16:11:05" #ICML2017 Novartis Novartis presents CAR-T investigational cell therapy data during #ICML2017: https://t.co/9fx5E8oHDi https://t.co/QTu124toUw Novartis presents CAR-T investigational cell therapy data during #ICML2017: https://t.co/9fx5E8oHDi https://t.co/QTu124toUw
"07.06.2017 15:00:10" #AHS17BOS Novartis We’re excited to attend the @ahsheadache 59th Annual Scientific Meeting with @Amgen #AHS17BOS! https://t.co/mXECE3sd5H We’re excited to attend the @ahsheadache 59th Annual Scientific Meeting with @Amgen #AHS17BOS! https://t.co/mXECE3sd5H
"06.06.2017 06:17:22" #EC, #Novartis, #leukemia Novartis #EC approves Treatment-free Remission data inclusion in EU label for #Novartis chronic myeloid #leukemia drug: https://t.co/J68lZhxJnG #EC approves Treatment-free Remission data inclusion in EU label for #Novartis chronic myeloid #leukemia drug: https://t.co/J68lZhxJnG
"05.06.2017 17:40:39"  Novartis @slinger91 We saw your tweet. Please provide your contact info to msus.visioncare@alcon.com so we can follow up. @slinger91 We saw your tweet. Please provide your contact info to msus.visioncare@alcon.com so we can follow up.
"05.06.2017 13:00:08" #superbugs, #ASMicrobe Novartis A new Novartis drug candidate aims to target dangerous antibiotic-resistant bacteria https://t.co/n9Mti6r9jz #superbugs #ASMicrobe https://t.co/E9g9OlPq6X A new Novartis drug candidate aims to target dangerous antibiotic-resistant bacteria https://t.co/n9Mti6r9jz #superbugs #ASMicrobe https://t.co/E9g9OlPq6X
"05.06.2017 12:00:06" #ASCO17 Novartis Novartis shares a compound with cancer-fighting potential with academic scientists: https://t.co/R0FtUO51Co #ASCO17 https://t.co/YgPEar8xtD Novartis shares a compound with cancer-fighting potential with academic scientists: https://t.co/R0FtUO51Co #ASCO17 https://t.co/YgPEar8xtD
"05.06.2017 11:31:53" #Novartis, #advancedBC Novartis #Novartis announces groundbreaking collaboration with @IBMWatsonHealth in #advancedBC https://t.co/61AAYVxMIq #Novartis announces groundbreaking collaboration with @IBMWatsonHealth in #advancedBC https://t.co/61AAYVxMIq
"04.06.2017 16:00:03" #ICYMI, #advancedBC, #ASCO17 Novartis #ICYMI we presented updated data of Novartis CDK4/6 inhibitor in #advancedBC at #ASCO17 https://t.co/KaukwGbuEH #ICYMI we presented updated data of Novartis CDK4/6 inhibitor in #advancedBC at #ASCO17 https://t.co/KaukwGbuEH
"04.06.2017 14:04:59" #oncology, #ASCO17 Novartis One researcher’s visit to Shanghai opens doors to new lines of #oncology research https://t.co/lZt9R77YoU 
#ASCO17 https://t.co/LID8K8gAQk One researcher’s visit to Shanghai opens doors to new lines of #oncology research https://t.co/lZt9R77YoU 
#ASCO17 https://t.co/LID8K8gAQk
"04.06.2017 14:03:49" #Novartis, #melanoma, #ASCO17 Novartis #Novartis data from four studies show results for BRAF-mutant metastatic #melanoma patients https://t.co/TiwkDqgfeo #ASCO17 #Novartis data from four studies show results for BRAF-mutant metastatic #melanoma patients https://t.co/TiwkDqgfeo #ASCO17
"03.06.2017 13:00:05" #superbugs, #ASMicrobe Novartis New compound aims to attack dangerous antibiotic-resistant #superbugs https://t.co/tAZ6jvRpZo #ASMicrobe https://t.co/Jb5rqqhz4A New compound aims to attack dangerous antibiotic-resistant #superbugs https://t.co/tAZ6jvRpZo #ASMicrobe https://t.co/Jb5rqqhz4A
"03.06.2017 12:00:07" #ASCO17 Novartis Novartis researchers open up a new route to safeguard cells against cancer’s shredder #ASCO17 https://t.co/9REEYKEx7l https://t.co/S6feCxfhz8 Novartis researchers open up a new route to safeguard cells against cancer’s shredder #ASCO17 https://t.co/9REEYKEx7l https://t.co/S6feCxfhz8
"02.06.2017 18:31:19"  Novartis @Andreamch1 We saw your tweet. Pls call us at 1-888-669-6682 or visit our website: https://t.co/kUcNwHKR3w @Andreamch1 We saw your tweet. Pls call us at 1-888-669-6682 or visit our website: https://t.co/kUcNwHKR3w
"02.06.2017 12:57:48" #antibioticresistance, #ASMicrobe Novartis Novartis brings a new compound into human studies in the fight against #antibioticresistance https://t.co/UXip9Byzqc #ASMicrobe https://t.co/3gVK4Qx7W6 Novartis brings a new compound into human studies in the fight against #antibioticresistance https://t.co/UXip9Byzqc #ASMicrobe https://t.co/3gVK4Qx7W6
"02.06.2017 06:38:51" #advancedBC, #ASCO17 Novartis Novartis announces updated data on CDK4/6 inhibitor in #advancedBC at #ASCO17 https://t.co/KaukwFTTg7 Novartis announces updated data on CDK4/6 inhibitor in #advancedBC at #ASCO17 https://t.co/KaukwFTTg7
"01.06.2017 14:00:14" #psoriaticarthritis, #psoriasis, #TeamNPFcycle Novartis We’re proud to work with @NPF to support the >8 million Americans living w/ #psoriaticarthritis & #psoriasis through #TeamNPFcycle https://t.co/LJ9FneLe8L We’re proud to work with @NPF to support the >8 million Americans living w/ #psoriaticarthritis & #psoriasis through #TeamNPFcycle https://t.co/LJ9FneLe8L
"01.06.2017 04:00:05" #ASCO17 Novartis Scientists find a new way to save cells from a deadly game of cancer tag: https://t.co/ivIb6waYyR #ASCO17 https://t.co/Rxw1O7bnef Scientists find a new way to save cells from a deadly game of cancer tag: https://t.co/ivIb6waYyR #ASCO17 https://t.co/Rxw1O7bnef
"31.05.2017 17:10:38" #diarrhealdisease Novartis Breaking: developing a new possible treatment for a #diarrhealdisease without effective options https://t.co/KdkDBieilk https://t.co/nEoypXFBf5 Breaking: developing a new possible treatment for a #diarrhealdisease without effective options https://t.co/KdkDBieilk https://t.co/nEoypXFBf5
"31.05.2017 16:02:05" #CART, #CLL, #ASCO17 Novartis News is out on our #CART cell therapy candidate in combination w/ a BTK inhibitor in #CLL. More: #ASCO17 https://t.co/sRskqf5zpB https://t.co/ZGAb3yWdC2 News is out on our #CART cell therapy candidate in combination w/ a BTK inhibitor in #CLL. More: #ASCO17 https://t.co/sRskqf5zpB https://t.co/ZGAb3yWdC2
"31.05.2017 13:13:15"  Novartis @faryabi_r We saw your tweet. Please provide your contact info and location to complaints.phchrk@novartis.com so we can follow up. @faryabi_r We saw your tweet. Please provide your contact info and location to complaints.phchrk@novartis.com so we can follow up.
"31.05.2017 12:00:07" #LifewithMS, #WorldMSDay Novartis #LifewithMS doesn’t have to be confusing. This #WorldMSDay the MS: No Filter dictionary turns MS info into real talk https://t.co/q9aFhCYm9Y #LifewithMS doesn’t have to be confusing. This #WorldMSDay the MS: No Filter dictionary turns MS info into real talk https://t.co/q9aFhCYm9Y
"30.05.2017 17:04:25" #WorldMSDay, #lifewithMS Novartis We’re excited for #WorldMSDay tomorrow! Read here to debunk some common myths about MS and what #lifewithMS is like: https://t.co/LkcTxSO0an We’re excited for #WorldMSDay tomorrow! Read here to debunk some common myths about MS and what #lifewithMS is like: https://t.co/LkcTxSO0an
"29.05.2017 13:45:02" #ATS2017, #COPD, #HCP, #medics Novartis #ATS2017 may be over but we have a year-round hub of great #COPD info for #HCP & #medics here: https://t.co/03aWO5SErt #ATS2017 may be over but we have a year-round hub of great #COPD info for #HCP & #medics here: https://t.co/03aWO5SErt
"26.05.2017 20:03:20" #FDA, #Novartis, #NSCLC Novartis The #FDA has approved first-line use of a #Novartis therapy for certain patients w/ #NSCLC https://t.co/NDO6796D10. The #FDA has approved first-line use of a #Novartis therapy for certain patients w/ #NSCLC https://t.co/NDO6796D10.
"25.05.2017 17:23:19"  Novartis @sbiswal19 pls contact our local office in India by phone at +91 22 2495 8400 or click here: https://t.co/w2imRxXOEP @sbiswal19 pls contact our local office in India by phone at +91 22 2495 8400 or click here: https://t.co/w2imRxXOEP
"25.05.2017 07:00:02" #WHA70, #chronicdisease, #LMICs Novartis #WHA70 side event today discussing partnerships to fight rise of #chronicdisease in #LMICs -- follow @NCDAccess https://t.co/eSNUZ65ZnD #WHA70 side event today discussing partnerships to fight rise of #chronicdisease in #LMICs -- follow @NCDAccess https://t.co/eSNUZ65ZnD
"24.05.2017 16:45:04" #ATS2018 Novartis Thank you @atscommunity for yet another great congress. Looking forward to seeing you next year @ #ATS2018 in San Diego! https://t.co/nmVDWj2h0m Thank you @atscommunity for yet another great congress. Looking forward to seeing you next year @ #ATS2018 in San Diego! https://t.co/nmVDWj2h0m
"24.05.2017 13:45:02" #COPD, #ICS Novartis Together with @IPCRG we are committed to helping primary care HCPs navigate #COPD science in practice #ICS https://t.co/PBAAOekUAC Together with @IPCRG we are committed to helping primary care HCPs navigate #COPD science in practice #ICS https://t.co/PBAAOekUAC
"24.05.2017 11:00:07" #NCDs, #NovartisAccess Novartis Proud to partner w/ @ICRC to improve care & treatment for refugees in Lebanon suffering from #NCDs #NovartisAccess: https://t.co/pCYA85X97Z Proud to partner w/ @ICRC to improve care & treatment for refugees in Lebanon suffering from #NCDs #NovartisAccess: https://t.co/pCYA85X97Z
"24.05.2017 10:30:03" #WHA70 Novartis Working together with aid organizations, private sector partners can be part of the solution to fight NCDs in humanitarian settings #WHA70 https://t.co/mZ6BvhncZ0 Working together with aid organizations, private sector partners can be part of the solution to fight NCDs in humanitarian settings #WHA70 https://t.co/mZ6BvhncZ0
"24.05.2017 10:00:02" #WHA70 Novartis Humanitarian actors face challenges to diagnose and treat NCDs for a growing number of patients among refugee population #WHA70 Humanitarian actors face challenges to diagnose and treat NCDs for a growing number of patients among refugee population #WHA70
"24.05.2017 09:30:02" #WHA70 Novartis In the past refugees were mostly affected by infectious diseases. Today many are also afflicted with NCDs such as diabetes #WHA70 In the past refugees were mostly affected by infectious diseases. Today many are also afflicted with NCDs such as diabetes #WHA70
"24.05.2017 09:00:02" #WHA70 Novartis Today at #WHA70 public and private sectors discuss how to fight NCDs in humanitarian settings @yaleSPH @KenyaRedCross @NovoNordisk @IAPO Today at #WHA70 public and private sectors discuss how to fight NCDs in humanitarian settings @yaleSPH @KenyaRedCross @NovoNordisk @IAPO
"24.05.2017 08:00:06" #diabetes, #hypertension, #NCDs Novartis Think chronic diseases like #diabetes or #hypertension only impact the wealthy? Refugee populations also suffer from #NCDs. https://t.co/L67W3a1m4I Think chronic diseases like #diabetes or #hypertension only impact the wealthy? Refugee populations also suffer from #NCDs. https://t.co/L67W3a1m4I
"23.05.2017 13:50:01" #respiratory, #ATS2017 Novartis Another great Open Dialogue Series event for #respiratory complete. Big thanks to guest speaker @COPDFoundation. #ATS2017 Another great Open Dialogue Series event for #respiratory complete. Big thanks to guest speaker @COPDFoundation. #ATS2017
"23.05.2017 13:45:02" #COPD, #ATS2017, #HCP, #medics Novartis Looking for more information on #COPD at #ATS2017? We have a dedicated online resource for #HCP & #medics @epgonline https://t.co/lQ664esQgN Looking for more information on #COPD at #ATS2017? We have a dedicated online resource for #HCP & #medics @epgonline https://t.co/lQ664esQgN
"23.05.2017 12:50:08"  Novartis @aymancoolangle we saw your tweet. Otrivin is no longer a Novartis product. Please provide your contact details to GYY32477@gsk.com. @aymancoolangle we saw your tweet. Otrivin is no longer a Novartis product. Please provide your contact details to GYY32477@gsk.com.
"22.05.2017 21:00:04" #respiratory, #ATS2017 Novartis If #respiratory diseases affect women differently, should this be reflected in care? Hot topic @ our Open Dialogue Series today #ATS2017 https://t.co/hrRXhVTF5Z If #respiratory diseases affect women differently, should this be reflected in care? Hot topic @ our Open Dialogue Series today #ATS2017 https://t.co/hrRXhVTF5Z
"22.05.2017 18:46:12"  Novartis @raji_phartyma Pls contact our local office in Nigeria by phone at +234 1 700 9911 or find local office info here:  https://t.co/TkPKWfd0Qr @raji_phartyma Pls contact our local office in Nigeria by phone at +234 1 700 9911 or find local office info here:  https://t.co/TkPKWfd0Qr
"22.05.2017 17:58:04" #ICS, #COPD Novartis New resource launched @IPCRGSlovenia17 to help physicians make best use of #ICS  steroids in #COPD care https://t.co/8nRjItnhLG New resource launched @IPCRGSlovenia17 to help physicians make best use of #ICS  steroids in #COPD care https://t.co/8nRjItnhLG
"22.05.2017 17:58:01" #ATS2017, #respiratory Novartis We will be at #ATS2017 this week discussing #respiratory science, management and patient challenges https://t.co/IWpX3iVodV We will be at #ATS2017 this week discussing #respiratory science, management and patient challenges https://t.co/IWpX3iVodV
"22.05.2017 17:57:55" #ATS2017, #respiratory Novartis We're gearing up for our *7th* Open Dialogue Series @ #ATS2017. Excited to bring advocates together to discuss pt challenges in #respiratory We're gearing up for our *7th* Open Dialogue Series @ #ATS2017. Excited to bring advocates together to discuss pt challenges in #respiratory
"22.05.2017 17:57:45" #ATS2017, #respiratory, #clinicaltrials Novartis At #ATS2017? Visit the Clinical Trials Awareness area to explore our #respiratory #clinicaltrials. Details here: https://t.co/L8jHRsnYfD At #ATS2017? Visit the Clinical Trials Awareness area to explore our #respiratory #clinicaltrials. Details here: https://t.co/L8jHRsnYfD
"22.05.2017 11:36:47" #ICS, #COPD, #ATS2017 Novartis Proud to support new @IPCRG practical HCP guidance on #ICS  steroid use in #COPD care #ATS2017  https://t.co/L2p5oufu3m Proud to support new @IPCRG practical HCP guidance on #ICS  steroid use in #COPD care #ATS2017  https://t.co/L2p5oufu3m
"19.05.2017 14:00:06" #accesstomedicine Novartis We have long experience in measuring inputs and outputs. We must apply that to our #accesstomedicine efforts https://t.co/slxW5dgyI7 https://t.co/25tjM40XuL We have long experience in measuring inputs and outputs. We must apply that to our #accesstomedicine efforts https://t.co/slxW5dgyI7 https://t.co/25tjM40XuL
"19.05.2017 11:30:04"  Novartis ‘It’s now not just whether something is legal but whether it is perceived as right’ Our CCO on standards in @WSJRisk https://t.co/j3ht8y9PbT ‘It’s now not just whether something is legal but whether it is perceived as right’ Our CCO on standards in @WSJRisk https://t.co/j3ht8y9PbT
"19.05.2017 08:00:06" #BetterHeartsBetterCities Novartis See how @NovartisFDN’s #BetterHeartsBetterCities is fighting hypertension in Mongolia @DrAlexKumar @GdnHealthcare https://t.co/irq8yG5jde https://t.co/NZFI390hNk See how @NovartisFDN’s #BetterHeartsBetterCities is fighting hypertension in Mongolia @DrAlexKumar @GdnHealthcare https://t.co/irq8yG5jde https://t.co/NZFI390hNk
"18.05.2017 16:00:23" #accesstomedicine, #NovartisAccess Novartis We asked #accesstomedicine expert Prof Richard Laing to scrutinize #NovartisAccess https://t.co/QvHGb9quXa We asked #accesstomedicine expert Prof Richard Laing to scrutinize #NovartisAccess https://t.co/QvHGb9quXa
"18.05.2017 15:00:05"  Novartis Download @theNASEM report on US role in future of global health, w/ contributions from our Head GDD @VasNarasimhan: https://t.co/HdSDTLyrR1 https://t.co/RIFlZQJR73 Download @theNASEM report on US role in future of global health, w/ contributions from our Head GDD @VasNarasimhan: https://t.co/HdSDTLyrR1 https://t.co/RIFlZQJR73
"18.05.2017 13:15:03" #ASCO17, #ICML2017, #EHA2017 Novartis At #ASCO17, #ICML2017 AND #EHA2017, we'll be sharing data highlighting clinical results in cancer care. https://t.co/qCakA3iQog At #ASCO17, #ICML2017 AND #EHA2017, we'll be sharing data highlighting clinical results in cancer care. https://t.co/qCakA3iQog
"17.05.2017 16:00:10" #NovartisAccess Novartis How will we know if we reached our goal w/ #NovartisAccess? Measure. https://t.co/CTHaA7QKQB How will we know if we reached our goal w/ #NovartisAccess? Measure. https://t.co/CTHaA7QKQB
"17.05.2017 14:34:01" #urbanhealth, #BetterHeartsBetterCities Novartis Read about @NovartisFDN's new #urbanhealth initiative, #BetterHeartsBetterCities - addressing hypertension in LMICs.https://t.co/klGPvxih2n https://t.co/9YHRBnFrbX Read about @NovartisFDN's new #urbanhealth initiative, #BetterHeartsBetterCities - addressing hypertension in LMICs.https://t.co/klGPvxih2n https://t.co/9YHRBnFrbX
"17.05.2017 13:00:04" #accesstomedicine Novartis There’s a lack of evidence that #accesstomedicine programs work. @BUSPH aims to change that. https://t.co/gp9RixeYU5 There’s a lack of evidence that #accesstomedicine programs work. @BUSPH aims to change that. https://t.co/gp9RixeYU5
"17.05.2017 08:00:05" #WorldHypertensionDay, #urbanhealth, #BetterHeartsBetterCities Novartis On #WorldHypertensionDay, @NovartisFDN launched their new #urbanhealth initiative #BetterHeartsBetterCities. https://t.co/cqSl2iYDpM https://t.co/rM7EFx8yWP On #WorldHypertensionDay, @NovartisFDN launched their new #urbanhealth initiative #BetterHeartsBetterCities. https://t.co/cqSl2iYDpM https://t.co/rM7EFx8yWP
"16.05.2017 14:58:24"  Novartis Conclusion by @BUSPH: doing good is nice; evidence of how well you do it, better. https://t.co/m4zvmvTpgZ Conclusion by @BUSPH: doing good is nice; evidence of how well you do it, better. https://t.co/m4zvmvTpgZ
"15.05.2017 15:30:07" #NCD, #accesstomedicine, #novartisaccess Novartis BREAKING: Agreement w/ Pakistan to supply #NCD meds to poorest population https://t.co/RU4XlWhv9S #accesstomedicine #novartisaccess https://t.co/AGVI6D9OE3 BREAKING: Agreement w/ Pakistan to supply #NCD meds to poorest population https://t.co/RU4XlWhv9S #accesstomedicine #novartisaccess https://t.co/AGVI6D9OE3
"13.05.2017 13:00:10" #NCDs, #WEFAsean Novartis Educating youth critical to fighting #NCDs in SE Asia. Changing habits now will have major future https://t.co/thOAaoPDS5 #WEFAsean. https://t.co/SLvzPfvdiH Educating youth critical to fighting #NCDs in SE Asia. Changing habits now will have major future https://t.co/thOAaoPDS5 #WEFAsean. https://t.co/SLvzPfvdiH
"12.05.2017 14:27:55" #NovartisCPD2017, #ProudMoments2017 Novartis We 💖  the 24,500 Novartis employees who volunteered for #NovartisCPD2017. Join us in making more #ProudMoments2017 https://t.co/BlLXXHyoqK https://t.co/jZL1m8s1TT We 💖  the 24,500 Novartis employees who volunteered for #NovartisCPD2017. Join us in making more #ProudMoments2017 https://t.co/BlLXXHyoqK https://t.co/jZL1m8s1TT
"12.05.2017 13:00:08" #WEFAsean Novartis Learn more about the role of young people in fight against chronic disease in SE Asia at #WEFAsean. https://t.co/7DqdFqROcO https://t.co/ymrAghcgeT Learn more about the role of young people in fight against chronic disease in SE Asia at #WEFAsean. https://t.co/7DqdFqROcO https://t.co/ymrAghcgeT
"11.05.2017 15:07:19" #Turkey Novartis Let's play! Our colleagues in #Turkey joined forces to make toys for children 🇹🇷 https://t.co/VniMkDbDHh Let's play! Our colleagues in #Turkey joined forces to make toys for children 🇹🇷 https://t.co/VniMkDbDHh
"11.05.2017 15:00:19"  Novartis Spot the gnome! Today our colleagues at Hexal made art with senior citizens 🇩🇪 https://t.co/ClE8QZcOx8 Spot the gnome! Today our colleagues at Hexal made art with senior citizens 🇩🇪 https://t.co/ClE8QZcOx8
"11.05.2017 14:40:52" #NovartisCPD2017, #ProudMoments2017 Novartis Volunteering with the French Red Cross for #NovartisCPD2017 #ProudMoments2017 https://t.co/RZJRrEzO9X Volunteering with the French Red Cross for #NovartisCPD2017 #ProudMoments2017 https://t.co/RZJRrEzO9X
"11.05.2017 13:32:59" #NovartisCPD2017, #ProudMoments2017 Novartis Novartis employees in Indonesia raise funds to buy eyeglasses for local children. #NovartisCPD2017 #ProudMoments2017 https://t.co/w1DqL6y6aI Novartis employees in Indonesia raise funds to buy eyeglasses for local children. #NovartisCPD2017 #ProudMoments2017 https://t.co/w1DqL6y6aI
"11.05.2017 11:23:38" #givingback, #NovartisCPD2017, #ProudMoments2017 Novartis Novartis employees donate blood in Spain #givingback #NovartisCPD2017 #ProudMoments2017 https://t.co/LaUk49Y7MQ Novartis employees donate blood in Spain #givingback #NovartisCPD2017 #ProudMoments2017 https://t.co/LaUk49Y7MQ
"11.05.2017 09:47:07" #NovartisCPD2017, #ProudMoments2017 Novartis Novartis employees in Spain pose for a selfie with cerebral paralysis patients #NovartisCPD2017 #ProudMoments2017 https://t.co/Z8T0ZsMGt8 Novartis employees in Spain pose for a selfie with cerebral paralysis patients #NovartisCPD2017 #ProudMoments2017 https://t.co/Z8T0ZsMGt8
"11.05.2017 09:37:33" #NovartisCPD2017 Novartis Cheerful tunes from #NovartisCPD2017 https://t.co/j4EQ8U8AFi Cheerful tunes from #NovartisCPD2017 https://t.co/j4EQ8U8AFi
"11.05.2017 09:05:59"  Novartis One of our teams in Germany gets ready to volunteer. https://t.co/RtlvFSRpTn One of our teams in Germany gets ready to volunteer. https://t.co/RtlvFSRpTn
"11.05.2017 08:19:09" #NovartisCPD2017, #ProudMoments2017 Novartis 21 years of giving back: see how we've gotten our 👐 dirty through the decades: https://t.co/Ebh7A2TN52 #NovartisCPD2017 #ProudMoments2017 https://t.co/cpuqI6DJCl 21 years of giving back: see how we've gotten our 👐 dirty through the decades: https://t.co/Ebh7A2TN52 #NovartisCPD2017 #ProudMoments2017 https://t.co/cpuqI6DJCl
"11.05.2017 06:00:04" #cancer Novartis Novartis shares a compound with #cancer-fighting potential with academic scientists: https://t.co/Mwu9ddUYHm https://t.co/9Qa653Zprd Novartis shares a compound with #cancer-fighting potential with academic scientists: https://t.co/Mwu9ddUYHm https://t.co/9Qa653Zprd
"11.05.2017 05:37:55" #NovartisCPD2017 Novartis >24,500 Novartis employees are making a difference in their communities today—follow along #NovartisCPD2017 https://t.co/f7LfF8kI0z https://t.co/ffbAhoFgnT >24,500 Novartis employees are making a difference in their communities today—follow along #NovartisCPD2017 https://t.co/f7LfF8kI0z https://t.co/ffbAhoFgnT
"10.05.2017 11:51:12" #NovartisCPD2017, #ProudMoments2017 Novartis Hear from Christina in Brazil on why she’s volunteering for #NovartisCPD2017. #ProudMoments2017 https://t.co/SeNMHiV8x7 Hear from Christina in Brazil on why she’s volunteering for #NovartisCPD2017. #ProudMoments2017 https://t.co/SeNMHiV8x7
"09.05.2017 15:49:38" #FDA, #metastaticBC Novartis US Only: #FDA approves new combination package for two prescription #metastaticBC medicines. https://t.co/7ownxIwYw9 US Only: #FDA approves new combination package for two prescription #metastaticBC medicines. https://t.co/7ownxIwYw9
"09.05.2017 12:07:25" #NovartisCPD2017, #ProudMoments2017 Novartis On Thurs, our colleague Artem will be out there lending a hand for #NovartisCPD2017. #ProudMoments2017 https://t.co/kPUNjFyyBJ On Thurs, our colleague Artem will be out there lending a hand for #NovartisCPD2017. #ProudMoments2017 https://t.co/kPUNjFyyBJ
"09.05.2017 07:00:07"  Novartis Digital technology may help lower-income countries attract drug development work https://t.co/KXs7wW4zA9 https://t.co/uP9kVenvac Digital technology may help lower-income countries attract drug development work https://t.co/KXs7wW4zA9 https://t.co/uP9kVenvac
"08.05.2017 19:00:23"  Novartis @isreallysexy We saw your tweet. Please provide your contact info to usdrugsafety.operations@novartis.com so we can follow up. @isreallysexy We saw your tweet. Please provide your contact info to usdrugsafety.operations@novartis.com so we can follow up.
"08.05.2017 16:00:05" #AlconEyeCare, #ASCRSASOA2017 Novartis #AlconEyeCare joins #ASCRSASOA2017 in celebrating 50 years of phaco. Swing by Booth 1623 & snap a photo of their historical phaco machines. https://t.co/kb672DIbIw #AlconEyeCare joins #ASCRSASOA2017 in celebrating 50 years of phaco. Swing by Booth 1623 & snap a photo of their historical phaco machines. https://t.co/kb672DIbIw
"08.05.2017 15:23:08" #NovartisCPD2017, #ProudMoments2017 Novartis Eveline has volunteered for 21 (!) years. Learn what drives employees like her: https://t.co/BlLXXHyoqK #NovartisCPD2017 #ProudMoments2017 https://t.co/6zdCQxhj1W Eveline has volunteered for 21 (!) years. Learn what drives employees like her: https://t.co/BlLXXHyoqK #NovartisCPD2017 #ProudMoments2017 https://t.co/6zdCQxhj1W
"08.05.2017 11:33:05" #NovartisCPD2017, #ProudMoments2017 Novartis 1 year ago… Ahead of #NovartisCPD2017, look back at volunteer highlights from 2016 https://t.co/G5NGvty0oU #ProudMoments2017 https://t.co/1Fnbz46hoz 1 year ago… Ahead of #NovartisCPD2017, look back at volunteer highlights from 2016 https://t.co/G5NGvty0oU #ProudMoments2017 https://t.co/1Fnbz46hoz
"07.05.2017 07:38:05" #NovartisCPD2017, #ProudMoments2017 Novartis Meet Dennis, a dedicated volunteer, then learn what inspires us at Novartis: https://t.co/BlLXXHyoqK #NovartisCPD2017 #ProudMoments2017 https://t.co/yhZGhaFHO9 Meet Dennis, a dedicated volunteer, then learn what inspires us at Novartis: https://t.co/BlLXXHyoqK #NovartisCPD2017 #ProudMoments2017 https://t.co/yhZGhaFHO9
"06.05.2017 11:00:04" #ASCRSASOA2017, #AlconEyeCare, #cataractsurgery, #IOL Novartis Today at #ASCRSASOA2017, #AlconEyeCare hosts a live #cataractsurgery w/the latest in #IOL technology: https://t.co/sMtvmDvto0 https://t.co/ypl5MWf2a6 Today at #ASCRSASOA2017, #AlconEyeCare hosts a live #cataractsurgery w/the latest in #IOL technology: https://t.co/sMtvmDvto0 https://t.co/ypl5MWf2a6
"06.05.2017 09:55:06" #Taiwan, #NovartisCPD2017, #ProudMoments2017 Novartis Here’s an upbeat message from our colleagues in #Taiwan. Help spread the word-RT! #NovartisCPD2017 #ProudMoments2017 https://t.co/BlLXXHyoqK https://t.co/XWEWO18ce3 Here’s an upbeat message from our colleagues in #Taiwan. Help spread the word-RT! #NovartisCPD2017 #ProudMoments2017 https://t.co/BlLXXHyoqK https://t.co/XWEWO18ce3
"06.05.2017 08:47:48" #WorldASDay, #ThisASLife Novartis This #WorldASDay @DanReynolds & Dr. Norton, a rheumatologist w/ AS, sit down in a new #ThisASLife Live! episode https://t.co/NGC2q7epOP https://t.co/NKw8vUVT8X This #WorldASDay @DanReynolds & Dr. Norton, a rheumatologist w/ AS, sit down in a new #ThisASLife Live! episode https://t.co/NGC2q7epOP https://t.co/NKw8vUVT8X
"05.05.2017 15:00:06" #ASCRSASOA2017, #AlconEyeCare, #cataractsurgery Novartis #ASCRSASOA2017 starts today! Our #AlconEyeCare team is there to present the latest innovations in #cataractsurgery: https://t.co/sMtvmDvto0. https://t.co/sHpI2AJoWu #ASCRSASOA2017 starts today! Our #AlconEyeCare team is there to present the latest innovations in #cataractsurgery: https://t.co/sMtvmDvto0. https://t.co/sHpI2AJoWu
"05.05.2017 14:00:12" #NovartisCPD2017, #ProudMoments Novartis Countdown to Community Partnership Day on May 11… follow along! #NovartisCPD2017 #ProudMoments https://t.co/mqkg2OuODQ Countdown to Community Partnership Day on May 11… follow along! #NovartisCPD2017 #ProudMoments https://t.co/mqkg2OuODQ
"05.05.2017 13:00:46" #NovartisCPD2016 Novartis ⚡️ “#NovartisCPD2016 memories”

https://t.co/UJZVGuynQ5 ⚡️ “#NovartisCPD2016 memories”

https://t.co/UJZVGuynQ5
"04.05.2017 20:00:07" #AlconEyeCare, #ASCRSASOA2017, #cataracts Novartis The #AlconEyeCare booth is almost ready for #ASCRSASOA2017! Stop by & learn about their latest treatment options for #cataracts. https://t.co/CmY3UHwQ3j The #AlconEyeCare booth is almost ready for #ASCRSASOA2017! Stop by & learn about their latest treatment options for #cataracts. https://t.co/CmY3UHwQ3j
"04.05.2017 15:13:08" #circa1997, #tbt, #NovartisCPD2017, #proudmoments2017 Novartis A peek at Novartis Community Day #circa1997 #tbt #NovartisCPD2017 #proudmoments2017 https://t.co/PEnmCBIcMN https://t.co/Za5GgLuXO1 A peek at Novartis Community Day #circa1997 #tbt #NovartisCPD2017 #proudmoments2017 https://t.co/PEnmCBIcMN https://t.co/Za5GgLuXO1
"04.05.2017 14:31:19" #WEFAfrica2017, #NCDs Novartis At #WEFAfrica2017 discussing disruptive partnerships to fight #NCDs. https://t.co/jchvZcfj2d At #WEFAfrica2017 discussing disruptive partnerships to fight #NCDs. https://t.co/jchvZcfj2d
"04.05.2017 13:39:25" #NCDs, #WEFAfrica2017 Novartis To effectively fight against #NCDs in Africa we need partnerships that don’t just work, but transform https://t.co/jchvZcfj2d #WEFAfrica2017 To effectively fight against #NCDs in Africa we need partnerships that don’t just work, but transform https://t.co/jchvZcfj2d #WEFAfrica2017
"04.05.2017 06:11:37"  Novartis BREAKING NEWS: Novartis exercises exclusive option with Conatus in NASH https://t.co/43XbgNEdFv https://t.co/yRv0Zi0SGS BREAKING NEWS: Novartis exercises exclusive option with Conatus in NASH https://t.co/43XbgNEdFv https://t.co/yRv0Zi0SGS
"04.05.2017 06:00:04" #cancer Novartis Scientists find a new way to save cells from a deadly game of #cancer tag: https://t.co/6h2JcLIzTo https://t.co/F1bu9Gag25 Scientists find a new way to save cells from a deadly game of #cancer tag: https://t.co/6h2JcLIzTo https://t.co/F1bu9Gag25
"02.05.2017 17:06:46" #ThisASLife, #WorldASDay Novartis What if you and your doctor had the same disease? @DanReynolds finds out in the next episode of #ThisASLife Live! honoring #WorldASDay https://t.co/4PZf8ZNUBX What if you and your doctor had the same disease? @DanReynolds finds out in the next episode of #ThisASLife Live! honoring #WorldASDay https://t.co/4PZf8ZNUBX
"02.05.2017 16:00:03" #HeartFailure2017 Novartis Thanks @escardio for another fantastic #HeartFailure2017. We’re already looking forward to next year! Thanks @escardio for another fantastic #HeartFailure2017. We’re already looking forward to next year!
"02.05.2017 07:00:05"  Novartis Will digital technology unlock the door to more clinical research projects in Africa? https://t.co/bhyziVDzwB https://t.co/kpR9OJtbZU Will digital technology unlock the door to more clinical research projects in Africa? https://t.co/bhyziVDzwB https://t.co/kpR9OJtbZU
"01.05.2017 14:04:29"  Novartis Novartis researchers open up a new route to safeguard cells against cancer’s shredder: https://t.co/u9WcRhTWgP https://t.co/7ISgW4y3oa Novartis researchers open up a new route to safeguard cells against cancer’s shredder: https://t.co/u9WcRhTWgP https://t.co/7ISgW4y3oa
"01.05.2017 13:21:23"  Novartis @bhartkumar847 We saw your tweet. Pls provide your contact info to india.drug_safety@novartis.com so we can follow up. @bhartkumar847 We saw your tweet. Pls provide your contact info to india.drug_safety@novartis.com so we can follow up.
"30.04.2017 10:30:03" #Egyptians Novartis Did you know the #Egyptians believed this? Check out more amazing facts about your heart here: https://t.co/40z5JFZVDd https://t.co/Z7MXL8Pv7H Did you know the #Egyptians believed this? Check out more amazing facts about your heart here: https://t.co/40z5JFZVDd https://t.co/Z7MXL8Pv7H
"29.04.2017 09:49:51" #migraine, #NotJustInYourHead, #AANAM Novartis Sensitivity to light, sound & smells: #migraine sufferers often endure these & more. #NotJustInYourHead #AANAM https://t.co/PboCQvi4XB Sensitivity to light, sound & smells: #migraine sufferers often endure these & more. #NotJustInYourHead #AANAM https://t.co/PboCQvi4XB
"29.04.2017 09:13:14"  Novartis How many times does the human heart beat in a day? How many times does the human heart beat in a day?
"28.04.2017 15:37:32" #Novartis, #FDA, #AML, #mastocytosis Novartis #Novartis receives #FDA approval for a new targeted therapy in #AML & three types of advanced systemic #mastocytosis https://t.co/oC9hSRtgLg #Novartis receives #FDA approval for a new targeted therapy in #AML & three types of advanced systemic #mastocytosis https://t.co/oC9hSRtgLg
"28.04.2017 10:00:13" #NTD Novartis It’s a wrap! View highlights from last week’s #NTD summit: https://t.co/fw8DxWGyn0 @gatesfoundation @WHO @evelyneleandro https://t.co/bBZKHHisqM It’s a wrap! View highlights from last week’s #NTD summit: https://t.co/fw8DxWGyn0 @gatesfoundation @WHO @evelyneleandro https://t.co/bBZKHHisqM
"27.04.2017 13:00:10" #Migraine, #AANAM Novartis #Migraine has serious social and economic consequences. RT to spread awareness for those impacted #AANAM https://t.co/myBMYEXEgw https://t.co/Ey3KqRuaPL #Migraine has serious social and economic consequences. RT to spread awareness for those impacted #AANAM https://t.co/myBMYEXEgw https://t.co/Ey3KqRuaPL
"27.04.2017 11:00:06" #Malaria, #endmalaria Novartis #Malaria poses a huge threat to children, esp. in Africa. But progress to #endmalaria is being made: https://t.co/WKt0N2vV0D https://t.co/2IiYpHaH6d #Malaria poses a huge threat to children, esp. in Africa. But progress to #endmalaria is being made: https://t.co/WKt0N2vV0D https://t.co/2IiYpHaH6d
"26.04.2017 17:19:03" #WorldIPDay Novartis A strong IP system is crucial to incentivize investment in healthcare R&D. On #WorldIPDay, find out why: https://t.co/tdiyR3Rb9s https://t.co/cuMmMQsMHo A strong IP system is crucial to incentivize investment in healthcare R&D. On #WorldIPDay, find out why: https://t.co/tdiyR3Rb9s https://t.co/cuMmMQsMHo
"26.04.2017 15:00:12" #EndMalaria Novartis David Reddy of @medsformalaria & Harald Nusser of Novartis discuss why partnerships are crucial to help #EndMalaria: https://t.co/TpLHVA6awn https://t.co/3JCK0obpn4 David Reddy of @medsformalaria & Harald Nusser of Novartis discuss why partnerships are crucial to help #EndMalaria: https://t.co/TpLHVA6awn https://t.co/3JCK0obpn4
"26.04.2017 14:30:05" #Migraine, #AANAM Novartis #Migraine is a severe neurological disease #AANAM https://t.co/RBqDhTKi6o https://t.co/abyNxyk7kD #Migraine is a severe neurological disease #AANAM https://t.co/RBqDhTKi6o https://t.co/abyNxyk7kD
"26.04.2017 13:21:42" #Migraines, #NotJustInYourHead, #AANAM Novartis Back pain & a 3-day headache. Each month. #Migraines cause misery for millions around the world. #NotJustInYourHead #AANAM https://t.co/4nHas1530J Back pain & a 3-day headache. Each month. #Migraines cause misery for millions around the world. #NotJustInYourHead #AANAM https://t.co/4nHas1530J
"26.04.2017 10:00:03" #WorldIPDay Novartis This #WorldIPDay, find out how IP rights have helped the healthcare industry improve & extend lives: https://t.co/R8S3417DGZ https://t.co/geHKNzoNKm This #WorldIPDay, find out how IP rights have helped the healthcare industry improve & extend lives: https://t.co/R8S3417DGZ https://t.co/geHKNzoNKm
"26.04.2017 08:05:26" #WorldIPDay Novartis On #WorldIPDay, our CEO Joe Jimenez talks about why strong IP rights are critical to promote healthcare innovation https://t.co/Z9OO7dkgig https://t.co/HBaEr3Wxuw On #WorldIPDay, our CEO Joe Jimenez talks about why strong IP rights are critical to promote healthcare innovation https://t.co/Z9OO7dkgig https://t.co/HBaEr3Wxuw
"25.04.2017 16:00:10"  Novartis Our Q1 financials results are out today—see how we kept up our innovation momentum in early 2017 $NVS https://t.co/hwp3r4lRyb Our Q1 financials results are out today—see how we kept up our innovation momentum in early 2017 $NVS https://t.co/hwp3r4lRyb
"25.04.2017 15:32:17"  Novartis Breaking news! We’re announcing an expanded collaboration w/ @Amgen in migraine. Read more here: https://t.co/ZBChyAdNRL Breaking news! We’re announcing an expanded collaboration w/ @Amgen in migraine. Read more here: https://t.co/ZBChyAdNRL
"25.04.2017 09:13:52" #endmalaria Novartis Today is World Malaria Day. Meet some of the people who have dedicated their careers to help #endmalaria: https://t.co/rCrt2UeRO7 https://t.co/tr8GJqzjDm Today is World Malaria Day. Meet some of the people who have dedicated their careers to help #endmalaria: https://t.co/rCrt2UeRO7 https://t.co/tr8GJqzjDm
"24.04.2017 17:33:15"  Novartis @skbothra We saw your tweet. Pls provide your contact info to india.drug_safety@novartis.com so we can follow up. @skbothra We saw your tweet. Pls provide your contact info to india.drug_safety@novartis.com so we can follow up.
"24.04.2017 16:00:10" #WorldMalariaDay, #EndMalaria Novartis Ahead of #WorldMalariaDay, find out how we’re playing our part to help #EndMalaria: https://t.co/sZjhVNHfTX https://t.co/w2KHkDrjFE Ahead of #WorldMalariaDay, find out how we’re playing our part to help #EndMalaria: https://t.co/sZjhVNHfTX https://t.co/w2KHkDrjFE
"24.04.2017 15:15:04" #NTDs, #NTDS Novartis 1 in 7 suffer #NTDs or their effects. Proud to join @FAIRMED59 & partners to co-found Swiss Alliance against #NTDS https://t.co/3X8ZC2NSTt 1 in 7 suffer #NTDs or their effects. Proud to join @FAIRMED59 & partners to co-found Swiss Alliance against #NTDS https://t.co/3X8ZC2NSTt
"24.04.2017 14:10:54" #migraine, #NotJustInYourHead, #AANAM Novartis Vertigo, nausea & a severe headache: #migraine sufferers often endure all this each month. #NotJustInYourHead #AANAM https://t.co/byHoYT7HKq Vertigo, nausea & a severe headache: #migraine sufferers often endure all this each month. #NotJustInYourHead #AANAM https://t.co/byHoYT7HKq
"24.04.2017 13:00:21"  Novartis We’re celebrating 1M LinkedIn followers! Join us to learn about scientific breakthroughs, exec viewpoints & more: https://t.co/yudCpvORsN https://t.co/BoBX21bynA We’re celebrating 1M LinkedIn followers! Join us to learn about scientific breakthroughs, exec viewpoints & more: https://t.co/yudCpvORsN https://t.co/BoBX21bynA
"24.04.2017 12:30:04" #ICYMI, #MS, #AANAM Novartis #ICYMI find out more about Novartis new real-world evidence in people with relapsing-remitting #MS: https://t.co/gmUNNusUII #AANAM #ICYMI find out more about Novartis new real-world evidence in people with relapsing-remitting #MS: https://t.co/gmUNNusUII #AANAM
"24.04.2017 11:00:06" #migraine, #AANAM Novartis A #migraine attack develops deep within the brain, causing changes in nerve cell activity and blood flow #AANAM  https://t.co/myBMYEXEgw https://t.co/uQWhj0cBOg A #migraine attack develops deep within the brain, causing changes in nerve cell activity and blood flow #AANAM  https://t.co/myBMYEXEgw https://t.co/uQWhj0cBOg
"24.04.2017 05:39:56" #MS, #AANAM Novartis BREAKING NEWS: Novartis announces new real-world data in relapsing-remitting #MS at #AANAM. Read more: https://t.co/gmUNNusUII BREAKING NEWS: Novartis announces new real-world data in relapsing-remitting #MS at #AANAM. Read more: https://t.co/gmUNNusUII
"24.04.2017 05:00:05"  Novartis As a child, Vicky Qi was an eyewitness to a healer. Now she pursues new treatments for cancer patients https://t.co/obESF4odug https://t.co/LJAWh8prtX As a child, Vicky Qi was an eyewitness to a healer. Now she pursues new treatments for cancer patients https://t.co/obESF4odug https://t.co/LJAWh8prtX
"23.04.2017 14:00:08" #migraine, #AANAM Novartis There is no single test to diagnose #migraine. >40% of patients go undiagnosed #AANAM  https://t.co/myBMYEXEgw https://t.co/QuPdTxA2os There is no single test to diagnose #migraine. >40% of patients go undiagnosed #AANAM  https://t.co/myBMYEXEgw https://t.co/QuPdTxA2os
"23.04.2017 08:30:04" #migraine, #AANAM Novartis The burden of #migraine is among the highest of all neurological diseases #AANAM https://t.co/myBMYEXEgw The burden of #migraine is among the highest of all neurological diseases #AANAM https://t.co/myBMYEXEgw
"22.04.2017 10:00:06" #EarthDay2017 Novartis The Physic Garden at our Basel campus invites visitors to discover pharmaceutical flora https://t.co/WmTJVPGdot #EarthDay2017 https://t.co/Ah4JdkdWG9 The Physic Garden at our Basel campus invites visitors to discover pharmaceutical flora https://t.co/WmTJVPGdot #EarthDay2017 https://t.co/Ah4JdkdWG9
"22.04.2017 09:25:55" #migraine, #AANAM Novartis Test your knowledge: According to WHO, #migraine is one of the _____ causes worldwide of years lost due to disability #AANAM Test your knowledge: According to WHO, #migraine is one of the _____ causes worldwide of years lost due to disability #AANAM
"22.04.2017 08:00:08" #EarthDay2017 Novartis Clean water is an #EarthDay2017 priority. @BasaidSm provides aid for water supply to rural communities globally https://t.co/qFAYGXKQFH https://t.co/HyL6DCjrHR Clean water is an #EarthDay2017 priority. @BasaidSm provides aid for water supply to rural communities globally https://t.co/qFAYGXKQFH https://t.co/HyL6DCjrHR
"22.04.2017 06:16:59" #EarthDay2017, #sustainable Novartis This #EarthDay2017 learn how #sustainable forestry projects benefit the environment & local communities long term https://t.co/eALZbCyqS1 https://t.co/nVfaqUyUcX This #EarthDay2017 learn how #sustainable forestry projects benefit the environment & local communities long term https://t.co/eALZbCyqS1 https://t.co/nVfaqUyUcX
"21.04.2017 19:47:42" #migraines, #NotJustInYourHead, #AANAM Novartis Blurred vision, nausea & fatigue: #migraines are much more than a headache. #NotJustInYourHead #AANAM https://t.co/b3nD0GPpJG Blurred vision, nausea & fatigue: #migraines are much more than a headache. #NotJustInYourHead #AANAM https://t.co/b3nD0GPpJG
"21.04.2017 15:30:03" #endmalaria Novartis Rising drug resistance marks a new front in the fight to #endmalaria. See how we’re working to tackle this threat https://t.co/rCrt2UeRO7 https://t.co/5MN8vqklqV Rising drug resistance marks a new front in the fight to #endmalaria. See how we’re working to tackle this threat https://t.co/rCrt2UeRO7 https://t.co/5MN8vqklqV
"21.04.2017 15:00:05" #endmalaria Novartis Dedicated community healthcare workers like Dismus in Zambia are crucial for helping to #endmalaria. Learn more: https://t.co/WKt0N2vV0D https://t.co/zabpWHnp2O Dedicated community healthcare workers like Dismus in Zambia are crucial for helping to #endmalaria. Learn more: https://t.co/WKt0N2vV0D https://t.co/zabpWHnp2O
"21.04.2017 07:45:17" #CombatNTDs Novartis #CombatNTDs https://t.co/Ge0GNFX3CZ #CombatNTDs https://t.co/Ge0GNFX3CZ
"21.04.2017 07:44:39" #CombatNTDs Novartis #CombatNTDs https://t.co/EtRj28wVg1 #CombatNTDs https://t.co/EtRj28wVg1
"20.04.2017 19:51:08" #NTDSummit17, #CombatNTDs Novartis Proud to have been part of #NTDSummit17 #CombatNTDs https://t.co/zikDaZsUn9 Proud to have been part of #NTDSummit17 #CombatNTDs https://t.co/zikDaZsUn9
"20.04.2017 17:00:06" #endmalaria Novartis Community healthcare workers are key in the fight to #endmalaria. Here’s a collection of scenes on the ground: https://t.co/WKt0N2vV0D https://t.co/3eNV9OITfL Community healthcare workers are key in the fight to #endmalaria. Here’s a collection of scenes on the ground: https://t.co/WKt0N2vV0D https://t.co/3eNV9OITfL
"20.04.2017 16:24:01"  Novartis @StaceyFurUK Thx for reaching out. Please contact our UK team at medinfo.uk@novartis.com for information. @StaceyFurUK Thx for reaching out. Please contact our UK team at medinfo.uk@novartis.com for information.
"20.04.2017 16:01:40" #NTDSummit17 Novartis #NTDSummit17 https://t.co/0vP8KJ5Tsf #NTDSummit17 https://t.co/0vP8KJ5Tsf
"20.04.2017 16:00:43" #NTDSummit17 Novartis #NTDSummit17 https://t.co/kBJEkiEeOL #NTDSummit17 https://t.co/kBJEkiEeOL
"20.04.2017 15:17:27" #endmalaria Novartis By working together we’ve come this far to help #endmalaria. Find out about our contribution: https://t.co/rCrt2UeRO7 https://t.co/nv9wJcBpNB By working together we’ve come this far to help #endmalaria. Find out about our contribution: https://t.co/rCrt2UeRO7 https://t.co/nv9wJcBpNB
"20.04.2017 15:13:23" #CombatNTDs Novartis This week, our CEO Joe Jimenez joined @BillGates & other leaders to recommit to the @WHO goal to #CombatNTDs : https://t.co/po3cYUS5lh https://t.co/7Rp7ZVoAS4 This week, our CEO Joe Jimenez joined @BillGates & other leaders to recommit to the @WHO goal to #CombatNTDs : https://t.co/po3cYUS5lh https://t.co/7Rp7ZVoAS4
"20.04.2017 12:01:03" #oncology, #chemicalbiology, #biochemistry, #AACR17 Novartis Patrick Chene on the multidisciplinary teams from #oncology, #chemicalbiology & #biochemistry that he works w/everyday #AACR17 https://t.co/7C1l3n7fsG Patrick Chene on the multidisciplinary teams from #oncology, #chemicalbiology & #biochemistry that he works w/everyday #AACR17 https://t.co/7C1l3n7fsG
"19.04.2017 23:00:03" #severeaplasticanemia, #NEJM Novartis #severeaplasticanemia is a rare disorder identified by pancytopenia. See @nih_nhlbi research on tx response in #NEJM https://t.co/nkZUgPlAO0 #severeaplasticanemia is a rare disorder identified by pancytopenia. See @nih_nhlbi research on tx response in #NEJM https://t.co/nkZUgPlAO0
"19.04.2017 21:17:38" #Novartis, #severeaplasticanemia Novartis #Novartis announces @nih_nhlbi data published in @NEJM on #severeaplasticanemia, a rare blood disorder  https://t.co/nkZUgPlAO0 #Novartis announces @nih_nhlbi data published in @NEJM on #severeaplasticanemia, a rare blood disorder  https://t.co/nkZUgPlAO0
"19.04.2017 12:50:17" #ReimagineMedicine, #Oncology Novartis Our structural biologists love puzzles & achieving what hasn’t been done before #ReimagineMedicine #Oncology https://t.co/AJZ6S8bfNu Our structural biologists love puzzles & achieving what hasn’t been done before #ReimagineMedicine #Oncology https://t.co/AJZ6S8bfNu
"18.04.2017 21:51:16"  Novartis @JustineW04 We saw your tweet. This is now a GSK Consumer Health product. Please contact GSK here: https://t.co/TDZjdGH2bX @JustineW04 We saw your tweet. This is now a GSK Consumer Health product. Please contact GSK here: https://t.co/TDZjdGH2bX
"18.04.2017 21:33:03"  Novartis @lialubo Pls contact our local office in Venezuela by phone at +58 212 273 2222 or click here: https://t.co/kgdCMj0ldg @lialubo Pls contact our local office in Venezuela by phone at +58 212 273 2222 or click here: https://t.co/kgdCMj0ldg
"18.04.2017 20:21:04"  Novartis .@evelyneleandro .@evelyneleandro, thanks for sharing your incredible story and apologies for the mix-up on age! .@evelyneleandro .@evelyneleandro, thanks for sharing your incredible story and apologies for the mix-up on age!
"18.04.2017 20:00:05"  Novartis https://t.co/D7TM2lVMik https://t.co/D7TM2lVMik
"18.04.2017 20:00:05" #LondonDeclaration, #NTDs, #NTDSummit17 Novartis #LondonDeclaration on #NTDs illustrates power of partnerships. Let’s learn from this & put rhetoric aside— Margaret Chan @WHO #NTDSummit17 https://t.co/zieQM4Z0j4 #LondonDeclaration on #NTDs illustrates power of partnerships. Let’s learn from this & put rhetoric aside— Margaret Chan @WHO #NTDSummit17 https://t.co/zieQM4Z0j4
"18.04.2017 19:47:02" #leprosy, #NTDSummit17 Novartis To take #leprosy diagnosis down from 200K cases per year to zero, we're employing new tools like contact tracing — J. Jimenez #NTDSummit17 https://t.co/zEYXvVJQqO To take #leprosy diagnosis down from 200K cases per year to zero, we're employing new tools like contact tracing — J. Jimenez #NTDSummit17 https://t.co/zEYXvVJQqO
"18.04.2017 18:07:03" #LondonDeclaration, #NTD, #NTDSummit17 Novartis #LondonDeclaration illustrates power of partnerships. Let’s learn from #NTD partnership & rhetoric aside— Margaret Chan @WHO #NTDSummit17 https://t.co/7331C9NoRD #LondonDeclaration illustrates power of partnerships. Let’s learn from #NTD partnership & rhetoric aside— Margaret Chan @WHO #NTDSummit17 https://t.co/7331C9NoRD
"18.04.2017 17:01:21" #NTDs, #NTDSummit17 Novartis Incredible commitment of pharma cos. giving away drugs in v. large quantities has led to huge progress against #NTDs @BillGates #NTDSummit17 https://t.co/9uKoDokLdJ Incredible commitment of pharma cos. giving away drugs in v. large quantities has led to huge progress against #NTDs @BillGates #NTDSummit17 https://t.co/9uKoDokLdJ
"18.04.2017 15:30:04" #leprosy, #NTDSummit17, #CombatNTDs Novartis When .@evelyneleandro was diagnosed w/ #leprosy in 2012, she had to be treated for 2 yrs. She was 13 yrs old. #NTDSummit17 #CombatNTDs https://t.co/Spi60oEVCz When .@evelyneleandro was diagnosed w/ #leprosy in 2012, she had to be treated for 2 yrs. She was 13 yrs old. #NTDSummit17 #CombatNTDs https://t.co/Spi60oEVCz
"18.04.2017 15:15:10" #NTDSummit17 Novartis Malawi healthworker Godfrey Cheleni presents a stick painted w/ bright colors indicating # of tablets to dispense based on size #NTDSummit17 https://t.co/M2ZALiSkvg Malawi healthworker Godfrey Cheleni presents a stick painted w/ bright colors indicating # of tablets to dispense based on size #NTDSummit17 https://t.co/M2ZALiSkvg
"18.04.2017 14:59:04" #NTD, #NTDSummit17 Novartis Before 2012, we weren’t coordinated, we would tackle one #NTD at a time instead of combining diseases in one area. — @BillGates #NTDSummit17 Before 2012, we weren’t coordinated, we would tackle one #NTD at a time instead of combining diseases in one area. — @BillGates #NTDSummit17
"18.04.2017 14:46:38" #leprosy, #NTDSummit17 Novartis To take #leprosy diagnosis down from 200K cases per year to zero, we're employing new tools like contract tracing — J. Jimenez #NTDSummit17 https://t.co/aoHo5GorSi To take #leprosy diagnosis down from 200K cases per year to zero, we're employing new tools like contract tracing — J. Jimenez #NTDSummit17 https://t.co/aoHo5GorSi
"18.04.2017 14:45:02" #leprosy, #NTDSummit17 Novartis "We’ve been able to reduce #leprosy prevalence by 95% & ensure that treatments reach those who need them." — Joe Jimenez #NTDSummit17 "We’ve been able to reduce #leprosy prevalence by 95% & ensure that treatments reach those who need them." — Joe Jimenez #NTDSummit17
"18.04.2017 14:14:14" #NTDSummit2017, #CombatNTDs Novartis Now on stage at #NTDSummit2017: @BillGates, H. Naito @EisaiUS, J. Jimenez @Novartis, I. Read @Pfizer, @alexanderdecroo & more #CombatNTDs https://t.co/lnoutVmdRG Now on stage at #NTDSummit2017: @BillGates, H. Naito @EisaiUS, J. Jimenez @Novartis, I. Read @Pfizer, @alexanderdecroo & more #CombatNTDs https://t.co/lnoutVmdRG
"18.04.2017 13:47:23" #NTDs, #NTDSummit17 Novartis Today our CEO Joe Jimenez spoke live with @business on what we’re doing to combat #NTDs #NTDSummit17 Watch: https://t.co/OU9SdXxUFt https://t.co/soRBmP1J1h Today our CEO Joe Jimenez spoke live with @business on what we’re doing to combat #NTDs #NTDSummit17 Watch: https://t.co/OU9SdXxUFt https://t.co/soRBmP1J1h
"18.04.2017 08:00:07" #NTDs, #ntdsummit17 Novartis In 2012, we signed up to tackle #NTDs. Today we're reaffirming this commitment: https://t.co/Y7mZD8HT22 #ntdsummit17 https://t.co/xlAyxqT1Dh In 2012, we signed up to tackle #NTDs. Today we're reaffirming this commitment: https://t.co/Y7mZD8HT22 #ntdsummit17 https://t.co/xlAyxqT1Dh
"18.04.2017 06:30:02" #DLBCL, #lymphoma Novartis Novartis receives @US_FDA Breakthrough Therapy designation for a potential therapy in r/r #DLBCL #lymphoma https://t.co/eH2bxnIhGD Novartis receives @US_FDA Breakthrough Therapy designation for a potential therapy in r/r #DLBCL #lymphoma https://t.co/eH2bxnIhGD
"18.04.2017 06:07:18"  Novartis BREAKING NEWS: Novartis announces clinical collaboration with @Allergan for NASH, a chronic liver disease https://t.co/B2vyetgcwb BREAKING NEWS: Novartis announces clinical collaboration with @Allergan for NASH, a chronic liver disease https://t.co/B2vyetgcwb
"17.04.2017 08:00:09" #leprosy, #NTDs Novartis ~75% of new #leprosy patients are found in SE Asia—that’s why @NovartisFDN supports screening in Myanmar: https://t.co/Y7mZD8HT22 #NTDs https://t.co/pNldWH5yLT ~75% of new #leprosy patients are found in SE Asia—that’s why @NovartisFDN supports screening in Myanmar: https://t.co/Y7mZD8HT22 #NTDs https://t.co/pNldWH5yLT
"15.04.2017 14:45:06" #NTDs, #ntdsummit17 Novartis Strength in R&D is one way we’re contributing to the fight against #NTDs: https://t.co/DDcGJY8dPy #ntdsummit17 https://t.co/7AyyfxqhDQ Strength in R&D is one way we’re contributing to the fight against #NTDs: https://t.co/DDcGJY8dPy #ntdsummit17 https://t.co/7AyyfxqhDQ
"14.04.2017 14:45:03" #leprosy, #NTDs, #ntdsummit17 Novartis We're making progress but more work to be done to eliminate #leprosy and other #NTDs https://t.co/Y7mZD8HT22 #ntdsummit17 https://t.co/3EpH1BwuYz We're making progress but more work to be done to eliminate #leprosy and other #NTDs https://t.co/Y7mZD8HT22 #ntdsummit17 https://t.co/3EpH1BwuYz
"12.04.2017 12:55:12"  Novartis @shampadhar Saw your tweet. Otrivin Oxy is now a GSK product. Please provide your contact details to GYY32477@gsk.com. @shampadhar Saw your tweet. Otrivin Oxy is now a GSK product. Please provide your contact details to GYY32477@gsk.com.
"08.04.2017 09:00:04" #livercancer Novartis Our research delivers a look at an experimental therapy for #livercancer https://t.co/LRZm550DMX https://t.co/L3lIn9tp50 Our research delivers a look at an experimental therapy for #livercancer https://t.co/LRZm550DMX https://t.co/L3lIn9tp50
"07.04.2017 15:30:08" #WorldHealthDay, #accesstohealthcare Novartis This #WorldHealthDay, discover how we’re working to extend #accesstohealthcare in developing countries: https://t.co/pfcouF8agS https://t.co/rCNqzHM10r This #WorldHealthDay, discover how we’re working to extend #accesstohealthcare in developing countries: https://t.co/pfcouF8agS https://t.co/rCNqzHM10r
"07.04.2017 15:00:06" #AACR17, #ReimagineMedicine Novartis At #AACR17, @DanaFarber’s William Hahn aims beyond the cancer genome. #ReimagineMedicine https://t.co/TkHqg7wPEP At #AACR17, @DanaFarber’s William Hahn aims beyond the cancer genome. #ReimagineMedicine https://t.co/TkHqg7wPEP
"06.04.2017 16:45:02" #ThisASLife, #yoga Novartis New #ThisASLife Live!: Dan Reynolds talks w/@RichAHoward about ankylosing spondylitis & the benefits of #yoga https://t.co/ZSUi2crdlz New #ThisASLife Live!: Dan Reynolds talks w/@RichAHoward about ankylosing spondylitis & the benefits of #yoga https://t.co/ZSUi2crdlz
"06.04.2017 09:04:53" #AACR17 Novartis Our researchers discovered an experimental therapy for advanced liver cancer, like HCC https://t.co/z5zPVDeDDE #AACR17 https://t.co/qzKJ7erEm1 Our researchers discovered an experimental therapy for advanced liver cancer, like HCC https://t.co/z5zPVDeDDE #AACR17 https://t.co/qzKJ7erEm1
"05.04.2017 16:30:09" #AACR17, #CancerResearch Novartis Take no prisoners when treating cancer. #AACR17 #CancerResearch https://t.co/CHJ0GMR4XP Take no prisoners when treating cancer. #AACR17 #CancerResearch https://t.co/CHJ0GMR4XP
"05.04.2017 15:30:08" #TeamScience, #AACR17 Novartis Inspiring! @JoeBiden calls for #TeamScience to advance cancer research. #AACR17 https://t.co/FTJijP5ShN Inspiring! @JoeBiden calls for #TeamScience to advance cancer research. #AACR17 https://t.co/FTJijP5ShN
"05.04.2017 14:30:05" #cancer, #AACR17, #ImmunoOnc Novartis Immunologist James Allison challenged the status quo for attacking #cancer. #AACR17 #ImmunoOnc https://t.co/1FYLLPTbun Immunologist James Allison challenged the status quo for attacking #cancer. #AACR17 #ImmunoOnc https://t.co/1FYLLPTbun
"04.04.2017 14:00:06" #AACR17, #oncology Novartis Jeff Engelman, #AACR17 presenter & head of Novartis #oncology, on what he hopes to achieve for patients: https://t.co/VmpfeTyYSL https://t.co/zNBLDT4pNh Jeff Engelman, #AACR17 presenter & head of Novartis #oncology, on what he hopes to achieve for patients: https://t.co/VmpfeTyYSL https://t.co/zNBLDT4pNh
"03.04.2017 14:33:34" #AACR17 Novartis Tackling cancer takes more than a village. Learn how our scientists across the world are working to beat it https://t.co/hPSfgg3YW5 #AACR17 https://t.co/TZuVxBhON8 Tackling cancer takes more than a village. Learn how our scientists across the world are working to beat it https://t.co/hPSfgg3YW5 #AACR17 https://t.co/TZuVxBhON8
"03.04.2017 10:00:04" #EMA, #Novartis, #NSCLC, #LCSM Novartis #EMA approves #Novartis targeted therapy for certain patients with advanced #NSCLC #LCSM https://t.co/71ilTJjEs8 #EMA approves #Novartis targeted therapy for certain patients with advanced #NSCLC #LCSM https://t.co/71ilTJjEs8
"03.04.2017 05:48:43" #EMA, #Novartis, #NSCLC, #LCSM Novartis #EMA approves #Novartis therapy for certain patients with advanced #NSCLC #LCSM https://t.co/71ilTJjEs8 #EMA approves #Novartis therapy for certain patients with advanced #NSCLC #LCSM https://t.co/71ilTJjEs8
"01.04.2017 14:00:06" #cancer, #immunoonc, #AACR17 Novartis Today kicks off the @AACR Annual Conference where our researchers present  #cancer & #immunoonc research: https://t.co/iJiKklPrV7 #AACR17 https://t.co/1HhqChcowM Today kicks off the @AACR Annual Conference where our researchers present  #cancer & #immunoonc research: https://t.co/iJiKklPrV7 #AACR17 https://t.co/1HhqChcowM
"31.03.2017 14:00:09" #chronicmyeloidleukemia, #AACR17 Novartis Cancer cells are masters of escape. Scientists are learning to outsmart them #chronicmyeloidleukemia: https://t.co/LxE3lyQEY2 #AACR17 https://t.co/WCN9RoJyUh Cancer cells are masters of escape. Scientists are learning to outsmart them #chronicmyeloidleukemia: https://t.co/LxE3lyQEY2 #AACR17 https://t.co/WCN9RoJyUh
"30.03.2017 14:00:58" #chronicmyeloidleukemia, #AACR17 Novartis How to catch a mutant? Our researchers are taking on #chronicmyeloidleukemia with a 2-pronged attack: https://t.co/LxE3lyQEY2 #AACR17 https://t.co/pjlJoEWDSP How to catch a mutant? Our researchers are taking on #chronicmyeloidleukemia with a 2-pronged attack: https://t.co/LxE3lyQEY2 #AACR17 https://t.co/pjlJoEWDSP
"29.03.2017 20:57:56"  Novartis .@US_FDA has granted priority review for CAR-T cell therapy for r/r ALL in children and young adults https://t.co/1DyRUZ0MYR .@US_FDA has granted priority review for CAR-T cell therapy for r/r ALL in children and young adults https://t.co/1DyRUZ0MYR
"29.03.2017 14:00:17" #AACR17 Novartis Discover the stories & the people who are on the front lines of the fight against cancer: https://t.co/hPSfgg3YW5 #AACR17 https://t.co/u5LIQwUdiu Discover the stories & the people who are on the front lines of the fight against cancer: https://t.co/hPSfgg3YW5 #AACR17 https://t.co/u5LIQwUdiu
"28.03.2017 14:30:03" #ImmunoOnc, #AACR17 Novartis What’s it like to be a postdoc in an #ImmunoOnc lab at Novartis? https://t.co/XAYVvfjSlA #AACR17 https://t.co/JtXu1gMTjk What’s it like to be a postdoc in an #ImmunoOnc lab at Novartis? https://t.co/XAYVvfjSlA #AACR17 https://t.co/JtXu1gMTjk
"27.03.2017 16:30:05" #AACR17 Novartis We’re passionate about reimagining medicine & the impact it could have on patients: https://t.co/B1VJY66onf 🔬 #AACR17 https://t.co/exTbeyQIOe We’re passionate about reimagining medicine & the impact it could have on patients: https://t.co/B1VJY66onf 🔬 #AACR17 https://t.co/exTbeyQIOe
"27.03.2017 14:30:55" #AACR17 Novartis Our compound counters the genome reprogramming of cancer cells in the lab: https://t.co/RtYSXlkZvu #AACR17 https://t.co/U8mb5bijyo Our compound counters the genome reprogramming of cancer cells in the lab: https://t.co/RtYSXlkZvu #AACR17 https://t.co/U8mb5bijyo
"26.03.2017 12:00:06" #SandozHACk, #accesstohealthcare Novartis Winners of @Sandoz_Global's #SandozHACk are finding new ways to expand #accesstohealthcare: https://t.co/T5ArvhMZpU https://t.co/x7NEBemLSr Winners of @Sandoz_Global's #SandozHACk are finding new ways to expand #accesstohealthcare: https://t.co/T5ArvhMZpU https://t.co/x7NEBemLSr
"24.03.2017 17:45:05"  Novartis Honored to rank in @PatientView survey in top 3 companies w/ the best reputation among patient groups. More here: https://t.co/bDVtFg5IRj https://t.co/KGWDoX8HWH Honored to rank in @PatientView survey in top 3 companies w/ the best reputation among patient groups. More here: https://t.co/bDVtFg5IRj https://t.co/KGWDoX8HWH
"23.03.2017 10:00:04"  Novartis Welcome to the board of @NovartisFDN, @VasNarasimhan! Learn more about his appointment: https://t.co/Y72zQvAnTE https://t.co/ipj0zCTM7r Welcome to the board of @NovartisFDN, @VasNarasimhan! Learn more about his appointment: https://t.co/Y72zQvAnTE https://t.co/ipj0zCTM7r
"22.03.2017 20:40:15"  Novartis @everythingexpl1 We saw your tweet. Please provide your contact details to product.security@novartis.com so that we can follow up. @everythingexpl1 We saw your tweet. Please provide your contact details to product.security@novartis.com so that we can follow up.
"21.03.2017 13:00:12"  Novartis At this year’s Maui Derm for Dermatologists, we presented new IL-17A psoriasis data for the first time. Learn more: https://t.co/N2VNEeAtJE At this year’s Maui Derm for Dermatologists, we presented new IL-17A psoriasis data for the first time. Learn more: https://t.co/N2VNEeAtJE
"21.03.2017 08:23:31" #Novartis, #psoriasis Novartis BREAKING NEWS: #Novartis announces new first of its kind data in #psoriasis. Find out more here: https://t.co/N2VNEeAtJE BREAKING NEWS: #Novartis announces new first of its kind data in #psoriasis. Find out more here: https://t.co/N2VNEeAtJE
"18.03.2017 13:05:27" #WorldGlaucomaWeek Novartis When it comes to glaucoma, early diagnosis is key. #WorldGlaucomaWeek https://t.co/DukOHq8suU When it comes to glaucoma, early diagnosis is key. #WorldGlaucomaWeek https://t.co/DukOHq8suU
"18.03.2017 13:01:51" #BrainWeek Novartis Tiny but mighty. Zebrafish brains are perfect for our research. Read why: https://t.co/71cuiH9gq6 #BrainWeek via @NovartisScience https://t.co/aYDddArQhZ Tiny but mighty. Zebrafish brains are perfect for our research. Read why: https://t.co/71cuiH9gq6 #BrainWeek via @NovartisScience https://t.co/aYDddArQhZ
"17.03.2017 15:24:54"  Novartis @liamtheking Saw your tweet. Lamisil is now a GSK product. Please provide your contact details to AEReporting@gsk.com. @liamtheking Saw your tweet. Lamisil is now a GSK product. Please provide your contact details to AEReporting@gsk.com.
"17.03.2017 14:37:51" #WorldGlaucomaWeek Novartis Age, ethnicity, diabetes & hereditary factors all increase the risk of glaucoma. #WorldGlaucomaWeek https://t.co/hSRYNOGsCL Age, ethnicity, diabetes & hereditary factors all increase the risk of glaucoma. #WorldGlaucomaWeek https://t.co/hSRYNOGsCL
"17.03.2017 11:23:44" #BrainWeek Novartis What do fruit flies & humans have in common? More than you think! https://t.co/PV79ML38Zk  #BrainWeek via @NovartisScience https://t.co/B22rUD9ctb What do fruit flies & humans have in common? More than you think! https://t.co/PV79ML38Zk  #BrainWeek via @NovartisScience https://t.co/B22rUD9ctb
"16.03.2017 14:56:26" #WorldGlaucomaWeek Novartis "My eye pressure was astronomical. I had no clue." Discover the causes & effects of glaucoma #WorldGlaucomaWeek https://t.co/q6VE8CmaN5 "My eye pressure was astronomical. I had no clue." Discover the causes & effects of glaucoma #WorldGlaucomaWeek https://t.co/q6VE8CmaN5
"16.03.2017 08:57:27" #BrainWeek Novartis These root-like dendrites are helping scientists study brain diseases. Discover how: https://t.co/ermfQiPb0k #BrainWeek via @NovartisScience https://t.co/UuKTz6IvMX These root-like dendrites are helping scientists study brain diseases. Discover how: https://t.co/ermfQiPb0k #BrainWeek via @NovartisScience https://t.co/UuKTz6IvMX
"15.03.2017 15:02:34" #WorldGlaucomaWeek Novartis It’s estimated that by 2040, glaucoma diagnoses could reach 111 million. #WorldGlaucomaWeek https://t.co/ofM9I1Fnmb It’s estimated that by 2040, glaucoma diagnoses could reach 111 million. #WorldGlaucomaWeek https://t.co/ofM9I1Fnmb
"15.03.2017 13:47:01" #BrainWeek Novartis New research is opening our eyes to the cause of vision loss: https://t.co/3DXR3xvsvt #BrainWeek via @NovartisScience https://t.co/OWSJsDFSdQ New research is opening our eyes to the cause of vision loss: https://t.co/3DXR3xvsvt #BrainWeek via @NovartisScience https://t.co/OWSJsDFSdQ
"14.03.2017 15:45:06" #WorldGlaucomaWeek Novartis It’s #WorldGlaucomaWeek, so we’re shining a light on the “silent thief” of sight. https://t.co/J24fDHnRd2 It’s #WorldGlaucomaWeek, so we’re shining a light on the “silent thief” of sight. https://t.co/J24fDHnRd2
"14.03.2017 13:46:01" #raredisease, #BrainWeek Novartis How might we restore sociability in patients with a #raredisease? https://t.co/7huXIouS9R #BrainWeek via @NovartisScience https://t.co/RO8BU5hG0M How might we restore sociability in patients with a #raredisease? https://t.co/7huXIouS9R #BrainWeek via @NovartisScience https://t.co/RO8BU5hG0M
"14.03.2017 13:15:47" #BrainWeek Novartis It’s #BrainWeek, so we’re sharing some cool science stories from our colleagues at @NovartisScience that'll get your neurons firing! https://t.co/YVVdscd2pO It’s #BrainWeek, so we’re sharing some cool science stories from our colleagues at @NovartisScience that'll get your neurons firing! https://t.co/YVVdscd2pO
"14.03.2017 12:00:06"  Novartis The FDA approval of our CDK 4/6 inhibitor resulted from our dedication to science and collaboration. @JayBradner https://t.co/YSbdgaKskO https://t.co/hUlAbmkPUb The FDA approval of our CDK 4/6 inhibitor resulted from our dedication to science and collaboration. @JayBradner https://t.co/YSbdgaKskO https://t.co/hUlAbmkPUb
"14.03.2017 11:00:03" #metastaticBC Novartis “Things get bad & scary...sometimes. You have to accept what’s beyond your control.” More on life w/ #metastaticBC: https://t.co/27A4Bfetzc “Things get bad & scary...sometimes. You have to accept what’s beyond your control.” More on life w/ #metastaticBC: https://t.co/27A4Bfetzc
"13.03.2017 21:15:02" #metastaticBC Novartis Life w/ #metastaticBC has changed in the past few decades. One woman faces each day w/ hope & her support system. https://t.co/27A4Bfetzc Life w/ #metastaticBC has changed in the past few decades. One woman faces each day w/ hope & her support system. https://t.co/27A4Bfetzc
"13.03.2017 21:00:03" #metastaticBC Novartis Thank you to all patients who took part in the #metastaticBC clinical trials. Learn why we couldn’t do it w/o you https://t.co/n3PFiIm9n9 Thank you to all patients who took part in the #metastaticBC clinical trials. Learn why we couldn’t do it w/o you https://t.co/n3PFiIm9n9
"13.03.2017 20:29:58" #metastaticBC Novartis Learn what Novartis Oncology CEO Bruno Strigini has to say about the newest treatment option in #metastaticBC. https://t.co/J3JQp9KfHu https://t.co/piPn6Y5dqU Learn what Novartis Oncology CEO Bruno Strigini has to say about the newest treatment option in #metastaticBC. https://t.co/J3JQp9KfHu https://t.co/piPn6Y5dqU
"13.03.2017 20:20:03"  Novartis New treatments are possible because of all of you who support clinical trials. https://t.co/J3JQp9KfHu https://t.co/JlqVzds7sX New treatments are possible because of all of you who support clinical trials. https://t.co/J3JQp9KfHu https://t.co/JlqVzds7sX
"13.03.2017 19:54:53" #FDA Novartis Big thanks to the patients and clinicians who contributed to today’s #FDA approval https://t.co/YSbdgaKskO Big thanks to the patients and clinicians who contributed to today’s #FDA approval https://t.co/YSbdgaKskO
"13.03.2017 19:45:58" #FDA, #metastaticBC Novartis #FDA approves new therapy for women with #metastaticBC in the US. https://t.co/YSbdgaKskO #FDA approves new therapy for women with #metastaticBC in the US. https://t.co/YSbdgaKskO
"13.03.2017 18:15:04" #SandozHACk Novartis It’s a wrap! #SandozHACk saw 3 teams awarded for their plans to increase healthcare access in developing countries: https://t.co/Xz72yV29V9 https://t.co/N1s22wqsHa It’s a wrap! #SandozHACk saw 3 teams awarded for their plans to increase healthcare access in developing countries: https://t.co/Xz72yV29V9 https://t.co/N1s22wqsHa
"10.03.2017 17:27:59" #SandozHACk, #accesstohealthcare Novartis A few highlights from yesterday’s #SandozHACk event, where young entrepreneurs pitched #accesstohealthcare proposals https://t.co/oJlxqSyaB9 https://t.co/roncoAnZQn A few highlights from yesterday’s #SandozHACk event, where young entrepreneurs pitched #accesstohealthcare proposals https://t.co/oJlxqSyaB9 https://t.co/roncoAnZQn
"09.03.2017 18:03:00" #SandozHACk Novartis Congratulations to all involved in today’s #SandozHACk! 🎉🎉🏆 https://t.co/JXpnPS8RW0 Congratulations to all involved in today’s #SandozHACk! 🎉🎉🏆 https://t.co/JXpnPS8RW0
"09.03.2017 14:23:29" #accesstohealthcare, #SandozHACk Novartis LIVE: Which 3 tech entrepreneurs will win €20K (each!) to fund their #accesstohealthcare ideas? Find out https://t.co/LsqFXnv6wf #SandozHACk https://t.co/1xhgBEqswZ LIVE: Which 3 tech entrepreneurs will win €20K (each!) to fund their #accesstohealthcare ideas? Find out https://t.co/LsqFXnv6wf #SandozHACk https://t.co/1xhgBEqswZ
"08.03.2017 19:15:04" #makingaccesshappen, #sandozhack Novartis Today, @Sandoz_Global CEO Richard Francis took time to hear from young entrepreneurs about their ideas for #makingaccesshappen #sandozhack https://t.co/O56m8HajO0 Today, @Sandoz_Global CEO Richard Francis took time to hear from young entrepreneurs about their ideas for #makingaccesshappen #sandozhack https://t.co/O56m8HajO0
"08.03.2017 14:52:09"  Novartis Tomorrow, 6 young tech entrepreneurs compete to turn their ideas for expanding healthcare access into reality. Tune in! https://t.co/tjvdlhkY1q Tomorrow, 6 young tech entrepreneurs compete to turn their ideas for expanding healthcare access into reality. Tune in! https://t.co/tjvdlhkY1q
"07.03.2017 15:00:06" #AAD17 Novartis This week we’re partnering w/ American Academy of Dermatology to increase the congress’s reach via VivindaTV  https://t.co/9fayVKYCGv #AAD17 https://t.co/KxeZK9uj5M This week we’re partnering w/ American Academy of Dermatology to increase the congress’s reach via VivindaTV  https://t.co/9fayVKYCGv #AAD17 https://t.co/KxeZK9uj5M
"07.03.2017 14:00:05" #SandozHACk, #accesstohealthcare Novartis This Thurs, follow #SandozHACk as 6 talented tech entrepreneurs pitch their ideas for expanding #accesstohealthcare https://t.co/pWTnVZteeq https://t.co/0IsQU5jgHb This Thurs, follow #SandozHACk as 6 talented tech entrepreneurs pitch their ideas for expanding #accesstohealthcare https://t.co/pWTnVZteeq https://t.co/0IsQU5jgHb
"06.03.2017 18:27:08"  Novartis @thereisnograce  We saw your tweet. Please provide your contact info to  colombia.farmacovigilancia@novartis.com so we can follow up. @thereisnograce  We saw your tweet. Please provide your contact info to  colombia.farmacovigilancia@novartis.com so we can follow up.
"06.03.2017 16:00:07" #AAD17, #Novartis, #psoriasis Novartis #AAD17 NEWS: #Novartis presents new #psoriasis retreatment data. Read more here: https://t.co/vRx6pg1L48 #AAD17 NEWS: #Novartis presents new #psoriasis retreatment data. Read more here: https://t.co/vRx6pg1L48
"06.03.2017 15:41:02" #Novartis, #psoriasis, #AAD17 Novartis BREAKING NEWS: #Novartis presents new #psoriasis data at #AAD17. Find out more here: https://t.co/vRx6pg1L48 BREAKING NEWS: #Novartis presents new #psoriasis data at #AAD17. Find out more here: https://t.co/vRx6pg1L48
"03.03.2017 09:56:36" #dermatology, #AAD17 Novartis This week we’re presenting #dermatology data in Orlando. Follow along #AAD17 https://t.co/YJ9m1qSilI This week we’re presenting #dermatology data in Orlando. Follow along #AAD17 https://t.co/YJ9m1qSilI
"01.03.2017 10:31:03" #DigitalHealth, #LMICs Novartis Read the report by @NovartisFDN, @nokia & @UNBBCom Working Group members on the promise of #DigitalHealth in #LMICs. https://t.co/ClJirlh2hq https://t.co/JZ5v9V6VXg Read the report by @NovartisFDN, @nokia & @UNBBCom Working Group members on the promise of #DigitalHealth in #LMICs. https://t.co/ClJirlh2hq https://t.co/JZ5v9V6VXg
"28.02.2017 16:47:02" #HIDS, #MKD, #RareEveryDay Novartis US ONLY: Patients w/ #HIDS (aka #MKD) are #RareEveryDay and may have fevers that last~5 days about 12x/year. https://t.co/PaWfmOU1Ye US ONLY: Patients w/ #HIDS (aka #MKD) are #RareEveryDay and may have fevers that last~5 days about 12x/year. https://t.co/PaWfmOU1Ye
"28.02.2017 16:02:01" #TRAPS, #periodicfever Novartis US ONLY: #TRAPS is a rare #periodicfever syndrome that can run in families. Learn and share https://t.co/INnaFRipxl US ONLY: #TRAPS is a rare #periodicfever syndrome that can run in families. Learn and share https://t.co/INnaFRipxl
"28.02.2017 15:17:01" #FMF, #RareEveryDay Novartis US ONLY: #FMF patients report missing out on social gatherings due to periodic fever attacks. #RareEveryDay https://t.co/XVYoZ1XYIG US ONLY: #FMF patients report missing out on social gatherings due to periodic fever attacks. #RareEveryDay https://t.co/XVYoZ1XYIG
"28.02.2017 14:32:01" #RareDiseaseDay, #RareEveryDay, #SJIA Novartis US ONLY: This #RareDiseaseDay, we are sharing the voices of parents whose children are living #RareEveryDay w/ #SJIA https://t.co/YgSwDRoLnC US ONLY: This #RareDiseaseDay, we are sharing the voices of parents whose children are living #RareEveryDay w/ #SJIA https://t.co/YgSwDRoLnC
"28.02.2017 13:48:02" #SJIA, #RareEveryDay Novartis US ONLY: For kids w/ #SJIA, living #RareEveryDay can mean missing ~10% of schooling annually. Learn more https://t.co/PabZeib05J US ONLY: For kids w/ #SJIA, living #RareEveryDay can mean missing ~10% of schooling annually. Learn more https://t.co/PabZeib05J
"28.02.2017 13:06:04"  Novartis This just in: Novartis shareholders have approved all resolutions at our 2017 Annual General Meeting $NVS https://t.co/L6ZSkW50rT This just in: Novartis shareholders have approved all resolutions at our 2017 Annual General Meeting $NVS https://t.co/L6ZSkW50rT
"28.02.2017 10:50:03" #MWC17, #digitalhealth Novartis Yesterday @NovartisFDN join @nokia & @UNBBCom Working Group members at #MWC17 to launch their #digitalhealth report. https://t.co/a4X6tLEnnv https://t.co/GSyQ2memHu Yesterday @NovartisFDN join @nokia & @UNBBCom Working Group members at #MWC17 to launch their #digitalhealth report. https://t.co/a4X6tLEnnv https://t.co/GSyQ2memHu
"28.02.2017 09:14:45"  Novartis Calling all shareholders – our $NVS Annual General Meeting is about to start. Watch the webcast: https://t.co/trBpLmv44V https://t.co/QOgrXKTvH3 Calling all shareholders – our $NVS Annual General Meeting is about to start. Watch the webcast: https://t.co/trBpLmv44V https://t.co/QOgrXKTvH3
"27.02.2017 13:00:04" #ESMO16 Novartis US Only: Are you a US HCP interested in sessions from #ESMO16? Novartis is providing you with access. Register: https://t.co/suQTtsT22Z https://t.co/A0BSOlP0xo US Only: Are you a US HCP interested in sessions from #ESMO16? Novartis is providing you with access. Register: https://t.co/suQTtsT22Z https://t.co/A0BSOlP0xo
"24.02.2017 21:14:27"  Novartis @LinesDavid we saw your tweet. Milbemax is no longer a Novartis product. Please contact Elanco Product Support at 1-877-352-6261. @LinesDavid we saw your tweet. Milbemax is no longer a Novartis product. Please contact Elanco Product Support at 1-877-352-6261.
"24.02.2017 16:53:02"  Novartis @LJPEREZR we saw your tweet. Senokot is now a GSK Consumer Health product. Please contact GSK here: https://t.co/er9Cjg5MDL @LJPEREZR we saw your tweet. Senokot is now a GSK Consumer Health product. Please contact GSK here: https://t.co/er9Cjg5MDL
"21.02.2017 15:00:01"  Novartis Why Jay Bradner, President of Novartis Institutes for BioMedical Research, hates the term “undruggable target.” https://t.co/5OHmGsF9IT Why Jay Bradner, President of Novartis Institutes for BioMedical Research, hates the term “undruggable target.” https://t.co/5OHmGsF9IT
"21.02.2017 12:00:05" #ReimagineMedicine Novartis A 3 million-molecule library, genome editing + tech partnerships... Discover R&D at Novartis: https://t.co/dWUjzi4Aan #ReimagineMedicine https://t.co/okkZqVFiUD A 3 million-molecule library, genome editing + tech partnerships... Discover R&D at Novartis: https://t.co/dWUjzi4Aan #ReimagineMedicine https://t.co/okkZqVFiUD
"20.02.2017 15:00:03"  Novartis “Test tube knees” help scientists use lab-grown cartilage to uncover new pathways into musculoskeletal diseases. https://t.co/Oktb3JFxoC “Test tube knees” help scientists use lab-grown cartilage to uncover new pathways into musculoskeletal diseases. https://t.co/Oktb3JFxoC
"17.02.2017 15:47:11"  Novartis @SuzanneRoynon  We saw your tweet. Please provide contact info and country of origin to complaints.phchrk@novartis.com so we can follow up. @SuzanneRoynon  We saw your tweet. Please provide contact info and country of origin to complaints.phchrk@novartis.com so we can follow up.
"17.02.2017 15:00:01"  Novartis An experimental drug could pave the way for the development of a host of inner-ear medicines. https://t.co/d9WxGNKu2G An experimental drug could pave the way for the development of a host of inner-ear medicines. https://t.co/d9WxGNKu2G
"17.02.2017 12:03:03" #NCDs, #NovartisAccess Novartis Proud to work with @meds_kenya to improve access-to-medicine in Kenya to fight #NCDs #NovartisAccess https://t.co/weg1hD32gG https://t.co/EUOs1nJyrW Proud to work with @meds_kenya to improve access-to-medicine in Kenya to fight #NCDs #NovartisAccess https://t.co/weg1hD32gG https://t.co/EUOs1nJyrW
"16.02.2017 17:38:21" #ReimagineMedicine Novartis Celebrating our 3rd consecutive ranking as world’s 2nd-most admired pharma co. @FortuneMagazine: #ReimagineMedicine: https://t.co/xylfGzlCuw https://t.co/MTOMg14n97 Celebrating our 3rd consecutive ranking as world’s 2nd-most admired pharma co. @FortuneMagazine: #ReimagineMedicine: https://t.co/xylfGzlCuw https://t.co/MTOMg14n97
"16.02.2017 15:00:05"  Novartis Researchers discover how “molecular glue” can silence a previously undruggable cancer target. https://t.co/L2uP3i2qqB Researchers discover how “molecular glue” can silence a previously undruggable cancer target. https://t.co/L2uP3i2qqB
"15.02.2017 16:02:03" #HeartMonth, #RiseAboveHF, #heartfailure Novartis This American #HeartMonth, #RiseAboveHF and learn about the impact of #heartfailure and its signs and symptoms at https://t.co/VqpnPbm2YY. https://t.co/yuXSoqaGJp This American #HeartMonth, #RiseAboveHF and learn about the impact of #heartfailure and its signs and symptoms at https://t.co/VqpnPbm2YY. https://t.co/yuXSoqaGJp
"15.02.2017 15:00:01"  Novartis How genomic sequencing technologies could make cancer diagnoses more precise. https://t.co/FfR8XIyvV2 How genomic sequencing technologies could make cancer diagnoses more precise. https://t.co/FfR8XIyvV2
"14.02.2017 15:00:01"  Novartis A new compound shows promising early results for killing malaria parasites in a single dose. https://t.co/hZCFcMgvRa A new compound shows promising early results for killing malaria parasites in a single dose. https://t.co/hZCFcMgvRa
"13.02.2017 18:15:04" #FutureOfHealthcare Novartis We’re joining forces with @THubHyd to help mentor healthcare & health tech startups. More here: https://t.co/MAbZj7gW1y #FutureOfHealthcare https://t.co/CqXHu3V9Zd We’re joining forces with @THubHyd to help mentor healthcare & health tech startups. More here: https://t.co/MAbZj7gW1y #FutureOfHealthcare https://t.co/CqXHu3V9Zd
"13.02.2017 15:00:04"  Novartis Shrouded in mystery, the role that microbes play in our body may hold the key to preventing and treating diseases. https://t.co/KTZZJ2Y8Ud Shrouded in mystery, the role that microbes play in our body may hold the key to preventing and treating diseases. https://t.co/KTZZJ2Y8Ud
"11.02.2017 12:00:04" #WomenInScience Novartis Today we’re celebrating #WomenInScience. Hear the stories of some of the women making a difference at Novartis: https://t.co/Lrpq0Ui2B4 💪💪 https://t.co/HBk2WNUdkF Today we’re celebrating #WomenInScience. Hear the stories of some of the women making a difference at Novartis: https://t.co/Lrpq0Ui2B4 💪💪 https://t.co/HBk2WNUdkF
"10.02.2017 15:00:05"  Novartis By exploring genetic mutations in brain tissue, researchers are shedding new light on epilepsy. https://t.co/wZUCB2pIC5 By exploring genetic mutations in brain tissue, researchers are shedding new light on epilepsy. https://t.co/wZUCB2pIC5
"10.02.2017 12:30:03"  Novartis Watch: In @ThisASLife Live!, musician Dan Reynolds talks with @helgiolafson about life with ankylosing spondylitis https://t.co/bvWGLWSlM5 Watch: In @ThisASLife Live!, musician Dan Reynolds talks with @helgiolafson about life with ankylosing spondylitis https://t.co/bvWGLWSlM5
"08.02.2017 14:09:50" #ReimagineMedicine Novartis See how we’re working to #ReimagineMedicine: https://t.co/v4rIDz9mdc 🔬⚗️ https://t.co/4tvnUdT69f See how we’re working to #ReimagineMedicine: https://t.co/v4rIDz9mdc 🔬⚗️ https://t.co/4tvnUdT69f
"07.02.2017 17:00:03"  Novartis A potential treatment for a rare immunodeficiency disease goes to clinical trials in near-record time. https://t.co/QNdZhtxGm9 A potential treatment for a rare immunodeficiency disease goes to clinical trials in near-record time. https://t.co/QNdZhtxGm9
"06.02.2017 15:12:28"  Novartis 🇮🇳 https://t.co/InDEhLCrRa 🇮🇳 https://t.co/InDEhLCrRa
"06.02.2017 15:00:05"  Novartis Find out how Novartis scientists are using "brains in a dish" to demystify neurological disorders. https://t.co/C9Gax1JX9s Find out how Novartis scientists are using "brains in a dish" to demystify neurological disorders. https://t.co/C9Gax1JX9s
"06.02.2017 12:09:24" #UrbanHealth Novartis Today @NovartisFDN is co-hosting its #UrbanHealth dialogue together w/ @IS_UrbanHealth @IAPartnership @ASSAf_Official @UniBasel_en @NYAMNYC https://t.co/IK8ATOxaI5 Today @NovartisFDN is co-hosting its #UrbanHealth dialogue together w/ @IS_UrbanHealth @IAPartnership @ASSAf_Official @UniBasel_en @NYAMNYC https://t.co/IK8ATOxaI5
"06.02.2017 09:39:04" #UrbanHealth Novartis Follow @NovartisFDN dialogue event today as they ask experts for new ideas to new #UrbanHealth challenges in Africa: https://t.co/pElMMDntAW https://t.co/vBF9aECR9C Follow @NovartisFDN dialogue event today as they ask experts for new ideas to new #UrbanHealth challenges in Africa: https://t.co/pElMMDntAW https://t.co/vBF9aECR9C
"04.02.2017 14:00:07"  Novartis Our compound counters the genome reprogramming of cancer cells in the lab https://t.co/AMNcht35NB https://t.co/LYnHWg285U Our compound counters the genome reprogramming of cancer cells in the lab https://t.co/AMNcht35NB https://t.co/LYnHWg285U
"04.02.2017 11:00:09"  Novartis Our compound showed promise in a model of B-cell lymphoma, reprogramming the genome and shrinking tumors https://t.co/AMNcht35NB https://t.co/sKMdzJehLp Our compound showed promise in a model of B-cell lymphoma, reprogramming the genome and shrinking tumors https://t.co/AMNcht35NB https://t.co/sKMdzJehLp
"04.02.2017 08:35:34" #WorldCancerDay Novartis This #WorldCancerDay, take a look at how scientists are learning to outsmart cancer using immunotherapy treatment: https://t.co/MMmRBIkSHD https://t.co/nmRrkmEEe7 This #WorldCancerDay, take a look at how scientists are learning to outsmart cancer using immunotherapy treatment: https://t.co/MMmRBIkSHD https://t.co/nmRrkmEEe7
"03.02.2017 15:00:06"  Novartis How many experiments does it take to target disease-causing parasites?  https://t.co/E4jHiv0DGG How many experiments does it take to target disease-causing parasites?  https://t.co/E4jHiv0DGG
"02.02.2017 16:31:52"  Novartis @cyrilksunny ​Thx for reaching out. Please contact your local Novartis office for more info on this topic: https://t.co/TkPKWfd0Qr @cyrilksunny ​Thx for reaching out. Please contact your local Novartis office for more info on this topic: https://t.co/TkPKWfd0Qr
"02.02.2017 16:29:31"  Novartis @dfabiam pls contact our local office in Colombia by phone at 018000916029 or click here: https://t.co/TkPKWfd0Qr @dfabiam pls contact our local office in Colombia by phone at 018000916029 or click here: https://t.co/TkPKWfd0Qr
"02.02.2017 15:00:05"  Novartis Oncologists now have treatments that harness the immune system to fight tumors 💪 https://t.co/VmTZtF8JN1 Oncologists now have treatments that harness the immune system to fight tumors 💪 https://t.co/VmTZtF8JN1
"01.02.2017 14:20:47"  Novartis A research breakthrough that wasn't supposed to be possible is challenging what we know about liver disease. https://t.co/QGEDhqrukQ A research breakthrough that wasn't supposed to be possible is challenging what we know about liver disease. https://t.co/QGEDhqrukQ
"31.01.2017 14:59:17"  Novartis Learn why NIBR President Jay Bradner believes in open-source science, why he values “brilliance & bravery," + more. https://t.co/qSpDFaT2xX Learn why NIBR President Jay Bradner believes in open-source science, why he values “brilliance & bravery," + more. https://t.co/qSpDFaT2xX
"31.01.2017 10:00:08" #chronicdisease, #LMICs, #NovartisAccess Novartis .@atmindex's @jayasreekiyer on the need to work together to stem tide of #chronicdisease in #LMICs. #NovartisAccess https://t.co/ivkIPb2xtY https://t.co/EB6NhfuVTz .@atmindex's @jayasreekiyer on the need to work together to stem tide of #chronicdisease in #LMICs. #NovartisAccess https://t.co/ivkIPb2xtY https://t.co/EB6NhfuVTz
"31.01.2017 07:32:59" #Novartis, #TSComplex Novartis @EU_Commission approves #Novartis drug for an additional #TSComplex indication https://t.co/4ZKMNnApI8 @EU_Commission approves #Novartis drug for an additional #TSComplex indication https://t.co/4ZKMNnApI8
"30.01.2017 15:41:34"  Novartis How advanced genome editing could revolutionize the treatment of cancer - and other diseases. https://t.co/izbFs0RDQ2 How advanced genome editing could revolutionize the treatment of cancer - and other diseases. https://t.co/izbFs0RDQ2
"29.01.2017 17:21:49" #leprosy, #WorldLeprosyDay Novartis Proud to support efforts toward a #leprosy free world w/ @NovartisFDN and partners around the world #WorldLeprosyDay https://t.co/J5ESGSzQvP https://t.co/KJAU64pwRd Proud to support efforts toward a #leprosy free world w/ @NovartisFDN and partners around the world #WorldLeprosyDay https://t.co/J5ESGSzQvP https://t.co/KJAU64pwRd
"27.01.2017 17:21:38" #ReimagineMedicine Novartis Facts, figures & results – it’s all here in our 2016 Annual Report: https://t.co/qsfwrnTIuB 📖📊🔬 #ReimagineMedicine https://t.co/c4pDiOPdM3 Facts, figures & results – it’s all here in our 2016 Annual Report: https://t.co/qsfwrnTIuB 📖📊🔬 #ReimagineMedicine https://t.co/c4pDiOPdM3
"27.01.2017 14:18:29" #NovartisAccess, #NCDs Novartis 120,000: # treatments #NovartisAccess delivered vs #NCDs since launch. Find out more in our 1-year report: https://t.co/WwP8di6SHq https://t.co/tcsE1q2v9W 120,000: # treatments #NovartisAccess delivered vs #NCDs since launch. Find out more in our 1-year report: https://t.co/WwP8di6SHq https://t.co/tcsE1q2v9W
"27.01.2017 13:43:39"  Novartis 10,000 tons: net reduction of our carbon emissions in 2016. Find out how in our CR Performance Report: https://t.co/7749h3XmFL 10,000 tons: net reduction of our carbon emissions in 2016. Find out how in our CR Performance Report: https://t.co/7749h3XmFL
"27.01.2017 12:40:12"  Novartis #3: our rank in @atmindex 2016. Find out why in our CR Performance Report: https://t.co/7749h3XmFL https://t.co/Gl52jaONwH #3: our rank in @atmindex 2016. Find out why in our CR Performance Report: https://t.co/7749h3XmFL https://t.co/Gl52jaONwH
"27.01.2017 09:51:14"  Novartis So how are we doing? You be the judge. View our 2016 CR Performance Report here: https://t.co/7749h3XmFL https://t.co/j4ixsz5o7u So how are we doing? You be the judge. View our 2016 CR Performance Report here: https://t.co/7749h3XmFL https://t.co/j4ixsz5o7u
"26.01.2017 20:00:19"  Novartis Hot off the press: We’ve just released our 2016 Corporate Responsibility Performance Report: https://t.co/jb0IqXlA5U https://t.co/C1bJsIXwjQ Hot off the press: We’ve just released our 2016 Corporate Responsibility Performance Report: https://t.co/jb0IqXlA5U https://t.co/C1bJsIXwjQ
"25.01.2017 19:00:09"  Novartis Signed, sealed, delivered! Today at our Basel HQ we announced $NVS 2016 annual results. Get the highlights: https://t.co/3pSistLaIw https://t.co/sUpOnvjGJ4 Signed, sealed, delivered! Today at our Basel HQ we announced $NVS 2016 annual results. Get the highlights: https://t.co/3pSistLaIw https://t.co/sUpOnvjGJ4
"25.01.2017 16:49:13"  Novartis @terratristate1 Thx for reaching out. Pls contact our US patient assistance program at 1-888-669-6682 so we can help. @terratristate1 Thx for reaching out. Pls contact our US patient assistance program at 1-888-669-6682 so we can help.
"25.01.2017 14:02:14"  Novartis @JulioBouza we saw your tweet. Maalox is now a GSK Consumer Health product. Please contact GSK here: https://t.co/TDZjdGH2bX @JulioBouza we saw your tweet. Maalox is now a GSK Consumer Health product. Please contact GSK here: https://t.co/TDZjdGH2bX
"25.01.2017 09:22:02"  Novartis This just in: 4th quarter 2016 financial results $NVS https://t.co/6fBnpLkcJq This just in: 4th quarter 2016 financial results $NVS https://t.co/6fBnpLkcJq
"24.01.2017 19:28:20"  Novartis Is pharmaceutical innovation on a downward slide? Our CEO Joe Jimenez doesn’t think so. Learn why: https://t.co/TM8KzaJy1S https://t.co/44gcHeqXT9 Is pharmaceutical innovation on a downward slide? Our CEO Joe Jimenez doesn’t think so. Learn why: https://t.co/TM8KzaJy1S https://t.co/44gcHeqXT9
"24.01.2017 17:21:02"  Novartis @Scarlett91360 we saw your tweet. Triaminic is now a GSK Consumer Health product. Please contact GSK here: https://t.co/TDZjdGH2bX @Scarlett91360 we saw your tweet. Triaminic is now a GSK Consumer Health product. Please contact GSK here: https://t.co/TDZjdGH2bX
"24.01.2017 16:00:10" #global100 Novartis Proud to have jumped 30 places in #global100 ranking as one of world’s most sustainable companies @corporateknight https://t.co/7L3vqExwYx https://t.co/dRWLJHbcUB Proud to have jumped 30 places in #global100 ranking as one of world’s most sustainable companies @corporateknight https://t.co/7L3vqExwYx https://t.co/dRWLJHbcUB
"21.01.2017 15:00:26"  Novartis Doctors lack medicines to reverse memory-robbing effects of Alzheimer’s disease. Here's what we're doing about it: https://t.co/ulj2DB9WO5 https://t.co/RpO2a5PZO1 Doctors lack medicines to reverse memory-robbing effects of Alzheimer’s disease. Here's what we're doing about it: https://t.co/ulj2DB9WO5 https://t.co/RpO2a5PZO1
"21.01.2017 14:30:09" #chronicdisease, #LMICs, #NovartisAccess, #talkingNCDs Novartis Together we’re committed to stemming the rise of #chronicdisease in #LMICs #NovartisAccess @NovartisFDN #talkingNCDs https://t.co/WrbKXLasUy Together we’re committed to stemming the rise of #chronicdisease in #LMICs #NovartisAccess @NovartisFDN #talkingNCDs https://t.co/WrbKXLasUy
"19.01.2017 16:05:02" #NCDs Novartis Innovation, partnership & political will critical to fight #NCDs in developing world, says our chairman J. Reinhardt https://t.co/uKQn03B76i Innovation, partnership & political will critical to fight #NCDs in developing world, says our chairman J. Reinhardt https://t.co/uKQn03B76i
"19.01.2017 16:00:11" #acccesstohealthcare, #wef Novartis This is why we’re joining @NCDAccess, a coalition of 22 companies dedicated to expanding #acccesstohealthcare #wef https://t.co/zjnwmYDrDa This is why we’re joining @NCDAccess, a coalition of 22 companies dedicated to expanding #acccesstohealthcare #wef https://t.co/zjnwmYDrDa
"18.01.2017 21:30:08" #NCDs, #LMICs Novartis Today @WEF we joined 21 pharma companies to launch Access Accelerated, a joint initiative to address #NCDs in #LMICs https://t.co/hBPhQ4KxpE Today @WEF we joined 21 pharma companies to launch Access Accelerated, a joint initiative to address #NCDs in #LMICs https://t.co/hBPhQ4KxpE
"18.01.2017 21:24:23"  Novartis Proud to be part of this effort https://t.co/eZWn6LkZPJ Proud to be part of this effort https://t.co/eZWn6LkZPJ
"18.01.2017 18:00:13" #NCDs Novartis Sustainable solutions needed vs #NCDs in developing world; private sector increasingly committed to this. @NCDAccess https://t.co/uKQn03B76i https://t.co/IwIYQNqXdM Sustainable solutions needed vs #NCDs in developing world; private sector increasingly committed to this. @NCDAccess https://t.co/uKQn03B76i https://t.co/IwIYQNqXdM
"18.01.2017 15:29:16" #wef, #accesstohealthcare, #NCDs Novartis At #wef, we’re joining @NCDAccess, @UICC and @WorldBank to accelerate #accesstohealthcare for #NCDs by 2030. https://t.co/3YBKteolOl At #wef, we’re joining @NCDAccess, @UICC and @WorldBank to accelerate #accesstohealthcare for #NCDs by 2030. https://t.co/3YBKteolOl
"17.01.2017 12:30:16"  Novartis Ahead of @wef @davos, our CEO Joe Jimenez argues for radical new thinking to tackle global healthcare challenges: https://t.co/y4LRmmngWy https://t.co/K5bYqxvnVy Ahead of @wef @davos, our CEO Joe Jimenez argues for radical new thinking to tackle global healthcare challenges: https://t.co/y4LRmmngWy https://t.co/K5bYqxvnVy
"16.01.2017 14:49:57"  Novartis @SummerChild_21 We saw your tweet. Please provide your contact info to
product.safetyunit@alcon.com so we can follow up. @SummerChild_21 We saw your tweet. Please provide your contact info to
product.safetyunit@alcon.com so we can follow up.
"12.01.2017 10:04:32" #accesstohealthcare Novartis How to help the 400M ppl who lack #accesstohealthcare? Our CEO Joe Jimenez weighs in @TIME: https://t.co/1pjayrb4gr https://t.co/Nf6nclnKUK How to help the 400M ppl who lack #accesstohealthcare? Our CEO Joe Jimenez weighs in @TIME: https://t.co/1pjayrb4gr https://t.co/Nf6nclnKUK
"11.01.2017 16:24:49"  Novartis We're there! https://t.co/iOErZhkNhQ We're there! https://t.co/iOErZhkNhQ
"10.01.2017 20:15:25"  Novartis @no1_uknow We saw your tweet. Please provide your contact info to msus.visioncare@alcon.com or call 1 800 757 9780 option 1 to follow up. @no1_uknow We saw your tweet. Please provide your contact info to msus.visioncare@alcon.com or call 1 800 757 9780 option 1 to follow up.
"09.01.2017 01:00:55" #ESMO16 Novartis US Only: Sad you missed out on a track presented at #ESMO16? We are providing US HCPs with access to the recordings. https://t.co/o3CdwcrHpT US Only: Sad you missed out on a track presented at #ESMO16? We are providing US HCPs with access to the recordings. https://t.co/o3CdwcrHpT
"06.01.2017 07:30:08" #cardiovascular Novartis We’re investing in new therapies with potential to reduce #cardiovascular risk in high-risk patients with unmet need https://t.co/Huxyunfjrw We’re investing in new therapies with potential to reduce #cardiovascular risk in high-risk patients with unmet need https://t.co/Huxyunfjrw
"04.01.2017 14:00:43" #digitalhealth Novartis Head of @NovartisFDN @AnnAertsNF shares lessons for making #digitalhealth interventions sustainable at scale @ProSyn https://t.co/oXWPB5d5JG Head of @NovartisFDN @AnnAertsNF shares lessons for making #digitalhealth interventions sustainable at scale @ProSyn https://t.co/oXWPB5d5JG
"31.12.2016 14:42:18" #ProudMoments2016 Novartis #ProudMoments2016 meet our people and join us to make more proud moments together: https://t.co/W8hgIQc1rG https://t.co/XX7nDMyPb9 #ProudMoments2016 meet our people and join us to make more proud moments together: https://t.co/W8hgIQc1rG https://t.co/XX7nDMyPb9
"31.12.2016 14:08:20" #ProudMoments2016 Novartis #ProudMoments2016 https://t.co/WAeukqkYAS #ProudMoments2016 https://t.co/WAeukqkYAS
"30.12.2016 20:37:56" #ProudMoments2016 Novartis #ProudMoments2016 https://t.co/oBXgmzhtzP #ProudMoments2016 https://t.co/oBXgmzhtzP
"29.12.2016 17:07:23" #ProudMoments2016 Novartis #ProudMoments2016 https://t.co/cvYRDNHiSk #ProudMoments2016 https://t.co/cvYRDNHiSk
"28.12.2016 18:32:40"  Novartis @sulina_84 Thanks for reaching out. Pls email us at india.communications@novartis.com​ so we can help. @sulina_84 Thanks for reaching out. Pls email us at india.communications@novartis.com​ so we can help.
"27.12.2016 15:01:23" #psoriasis, #ProudMoments2016 Novartis We commissioned a body painter to portray results of a survey of >8,000 ppl w/ #psoriasis #ProudMoments2016 https://t.co/aX7ONN00Xd https://t.co/vcubHRb6qG We commissioned a body painter to portray results of a survey of >8,000 ppl w/ #psoriasis #ProudMoments2016 https://t.co/aX7ONN00Xd https://t.co/vcubHRb6qG
"26.12.2016 15:01:13" #ProudMoments2016 Novartis 20+ Novartis and Alcon colleagues got a 3-hour training on how to guide blind people at this year’s Louis Braille festival #ProudMoments2016 https://t.co/lIkixMub7n 20+ Novartis and Alcon colleagues got a 3-hour training on how to guide blind people at this year’s Louis Braille festival #ProudMoments2016 https://t.co/lIkixMub7n
"25.12.2016 14:01:19" #ProudMoments2016 Novartis Happy holidays, Fröhliche Weihnachten, joyeux Noël, buon Natale… from our Basel campus to wherever you are! #ProudMoments2016 🎄 https://t.co/cp3uZx2Wkr Happy holidays, Fröhliche Weihnachten, joyeux Noël, buon Natale… from our Basel campus to wherever you are! #ProudMoments2016 🎄 https://t.co/cp3uZx2Wkr
"24.12.2016 16:01:35" #accesstohealthcare, #ProudMoments2016 Novartis .@sandoz_global’s HACk crowdsources #accesstohealthcare challenges #ProudMoments2016 https://t.co/l7mDXyug6u https://t.co/gDE5rgeGy2 .@sandoz_global’s HACk crowdsources #accesstohealthcare challenges #ProudMoments2016 https://t.co/l7mDXyug6u https://t.co/gDE5rgeGy2
"24.12.2016 14:30:42" #ProudMoments2016 Novartis Novartis campuses worldwide, including Origgio, Italy, welcomed associates & their families on Novartis Science Day #ProudMoments2016 https://t.co/UXgV6xtAZY Novartis campuses worldwide, including Origgio, Italy, welcomed associates & their families on Novartis Science Day #ProudMoments2016 https://t.co/UXgV6xtAZY
"23.12.2016 16:01:58" #vietnam, #ProudMoments2016 Novartis .@NovartisFDN is partnering with @PATHtweets to offer Communities for Healthy Hearts in #vietnam #ProudMoments2016 https://t.co/brZ7xMZ8Px https://t.co/YROUcEm3jK .@NovartisFDN is partnering with @PATHtweets to offer Communities for Healthy Hearts in #vietnam #ProudMoments2016 https://t.co/brZ7xMZ8Px https://t.co/YROUcEm3jK
"22.12.2016 15:06:07" #ProudMoments2016 Novartis #ProudMoments2016 https://t.co/NCaaWfxPOS #ProudMoments2016 https://t.co/NCaaWfxPOS
"21.12.2016 16:01:47" #ProudMoments2016 Novartis Proud to be helping urticaria patients break free from feeling constrained by their disease using emojis... what else! #ProudMoments2016 😊😞😂 https://t.co/a0AyQA5V64 Proud to be helping urticaria patients break free from feeling constrained by their disease using emojis... what else! #ProudMoments2016 😊😞😂 https://t.co/a0AyQA5V64
"21.12.2016 13:20:21"  Novartis US Only: The @myESMO Annual Meeting is over, but your access to recorded sessions is not! US HCPs can sign up here: https://t.co/vnC41fEUEa. US Only: The @myESMO Annual Meeting is over, but your access to recorded sessions is not! US HCPs can sign up here: https://t.co/vnC41fEUEa.
"21.12.2016 13:02:01" #infectiousdiseases Novartis Learn how our scientists could tackle a single target to potentially treat three #infectiousdiseases https://t.co/vymEM9UxGs https://t.co/J3kyJyePw4 Learn how our scientists could tackle a single target to potentially treat three #infectiousdiseases https://t.co/vymEM9UxGs https://t.co/J3kyJyePw4
"21.12.2016 02:05:02"  Novartis @wevertonsouza28 We saw your tweet. Please forward details of your complaint to business.practicesofficer@novartis.com. Thank you. @wevertonsouza28 We saw your tweet. Please forward details of your complaint to business.practicesofficer@novartis.com. Thank you.